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Abstract
Protein disulfide isomerase (PDI) is a multifunctional protein most well char­
acterized for its ability to form and exchange disulfide bonds (Darby et al., 1996). 
More recently, a host of other functions have been added to the resume of this protein, 
including denitrosation activity (Zai et al., 1999), mediation of integrin-dependent 
adhesion (Lahav et al., 2000), and copper binding activity (Narindrasorasak et al, 
2003). PDI is a 110 kDa homodimer and contains five domains, a-b-b’-a ’c (Darby et 
al, 1996). The a and a ’ domains contain the Cys-Gly-His-Cys active site residues 
responsible for the thiol-disulfide exchange reactions (Darby et al., 1996). Although 
this protein is predominantly localized within the endoplasmic reticulum depending 
on the cell type, PDI has also been found in secretory vesicles, the Golgi, and the 
plasma membrane (Akagi et al., 1988) of eukaryotic cells. In glial astrocytes, PDI 
is also found throughout the cytosol (Safran and Leonard, 1991), but its interaction 
between the cytoplasm and endoplasmic reticulum is not fully understood. Under is­
chemic stress, PDI is upregulated in rat forebrain cells, suggesting protection against 
cellular stresses (Tanaka et al, 1999). The localization of PDI in differentiated human 
neuroblastoma SH-SY5Y cells was probed by the development of a recombinant fusion 
protein between green fluorescent protein GFP and PDI. SH-SY5Y cells expressing 
the recombinant reporter protein were also exposed to oxidative and ischemic stress, 
and examined for characteristics of apoptosis. These cells demonstrated that PDI 
provides a significant decrease in apoptotic traits as compared to the control cells. 
It was observed that there was reduced nuclear condensation, and maintainence of 
mitochondrial membrane potential. Cells containing the recombinant protein also 
showed an increased number of viable cells when exposed to hypoxic stress. These 
results suggest that PDI plays a role in the protective mechanism towards cellular 
stress. Excessive neuronal loss induced by oxidative stress is often seen in patients 
due to aging, strokes, and neurodegenerative diseases. The results obtained by using 
this cell line for the study of neuronal cell death have potential implication for strokes 
and human neurodegenerative diseases.
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Chapter 1
General Introduction
1.1 Protein Disulfide Isomerase
There are a m ultitude of events tha t occur in the endoplasmic reticulum (ER) of 
the cell such as lipid biosynthesis, calcium storage, and most notably protein synthesis 
and modification. The ER is composed of a system of membranes tha t extends 
throughout the cytosol, and connects to the nuclear envelope. W ithin this dynamic 
network, lies a powerhouse of a protein, and with every new experiment another title 
is added to its host of newly discovered functions and activities. Protein disulfide 
isomerase (PDI), is most widely known for its role in protein folding and disulfide 
bond isomerization. Before PDI was classified, early work on the protein described 
an enzyme able to catalyze thiol exchange reactions in protein folding (Goldberger 
et al, 1964). Folding in vitro can take minutes to hours for disulfide formation 
to take place. In the 1964 paper by Goldberger and colleagues, the “microsomal 
protein” had a specific activity 88 times tha t of th e “microsome” alone. There is 
a high concentration of PDI found in the ER - approximately 0.2 mM (Lyles and 
Gilbert, 1991). Also, PDI has a low affinity interacting with its substrates. This 
lack of substrate specificity would be consistent with its ability to isomerize disulfide 
bonds in a myriad of different proteins.
1
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1.1.1 P D I Structure
Mammalian PDI is approximately 57 000 Da, and is made of approximately 
491 amino acid residues (Darby and Creighton, 1998). The length of the protein 
can be debatable depending on the inclusion of a leader peptide signal. Throughout 
this thesis, the human PDI sequence obtained from the cDNA from pET-1 la  will be 
used (Appendix A). This sequence matches the human PDI sequence patented by 
Kato and coworkers in 1991, with the removal of the beginning 20 amino acid signal 
sequence. S tructural analysis of the 120 residue a domain (Kemmink, et al., 1996), 
and 110 residue b domain (Kemmink, et al., 1999) of human PDI places it in the 
thioredoxin superfamily (SCOP 52833, CATH 3.40.30.10)(Murzin et al., 1995, Pearl 
et al., 2005). An NMR structure of the full length protein has not yet been eluci­
dated. The characteristic sequence Cys-Gly-His-Cys found in the active site domains 
of the protein bear high sequence and structural homology to another redox protein, 
thioredoxin, which is found in both prokaryotic and eukaryotic cells. The members 
of this superfamily share the vicinal thiols, but differ in the two amino acids found 
between, which can directly affect the catalytic activity of the protein (see section
1.1.2 Thioredoxin). The structure of mammalian PDI has been classified into five 
different domains; a, b, b’, a, and c (figure 1.1) (Kemmink et al., 1996). Although 
PDI is found predominantly in the ER, PDI has been identified as subunits of other 
proteins including prolyl-4-hydroxylase, an enzyme involved in post-translational hy- 
droxylation of peptidyl proline residues, and microsomal triglyceride transfer protein 
complex (M TP), a protein tha t transports triglyceride and cholesterol esters across 
membranes (W etterau et al., 1991). PDI has been found to have sequence homology 
with other proteins of unrelated function. For example, the b domain contains se­
quence homology to calsequesterin, a protein which pools calcium in the sarcoplasmic 
reticulum of muscle cells (Noiva, 1999). Located in the c-domain are acidic residues 
thought to bind calcium, which suggests tha t PDI has calcium storage and buffering 
capacity (Corbett et al., 1999).
2
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CGHC 
36 39 CGHC KDEL 384 387
Figure 1.1: The structural domains of mammalian PDI. Kemmink and coworkers 
(1996) proposed this model of the structural domains of PDI. The location of the 
active site cysteines are found in the a and a ’ domains. The b and b ’ domains are 
responsible for chaperonic activity, and the c domain contains the carboxyl-terminal 
KDEL ER retention signal. The residue numbering is consistent with the sequence 
found in Appendix A.
3
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The activities of isolated a and a ’domains are capable of catalyzing disulfide bond 
isomerization, but are less efficient than the entire PDI protein (Darby and Creighton, 
1995), giving further proof for the importance of the other domains in the protein. 
The b ’ domain of PDI can bind unstructured regions of polypeptide to assist in 
the folding process (Freedman et al., 2002). The importance of the b ’ domain to 
the chaperonic activity of PDI was demonstrated in a 2004 paper by Horibe and 
coworkers. By replacing the b domain in human protein disulfide isomerase related 
protein (hPDIR) with the b ’ domain from human PDI, the chaperonic activity of the 
protein was found to increase. The c domain has also been shown to help stabilize the 
chaperone function of the protein (Tian et al., 2004). Also contained in the c domain 
is the KDEL sequence which is characteristic of controlling ER retention. Figure 1.2 
shows the NMR structures of the a (left) and b (right) domains of PDI. Notice the 
two active site cysteines depicted in ball and stick imagery.
4
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Figure 1.2: Domains a and b of human PDI from www.pdb.org (Berman et al., 
2000) (Date accessed 04/05/05). Figure (A) shows only one of 40 NMR structures of 
isolated human PDI a (A) domain. The active site cysteines are shown in ball and 
stick representation, located at residues 36 and 39. Figure (B) shows only one of 24 
NMR structures of human PDI b (B) domain. Although not responsible for catalytic 
action, it is im portant for substrate stabilization. Accession number for the a domain 
is 1MEK, and b domain is 2BJX. The interactive Rasmol display was saved for each 
file, and structure modelling was done in Rasmol v.2.7.2.1.1.
5
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1.1.2 Thioredoxin
The thioredoxin (TRX) superfamily (SCOP 52833, CATH 3.40.30.10) consists of 
a group of proteins responsible for disulfide bond formation. The bacterial proteins 
include the Dsb (disulfide bond) and thioredoxin proteins. The bacterial disulfide 
bond (Dsb) proteins share the vicinal Cys residues in their active site (Table 1.1). 
The catalytic efficiency of the proteins are directed by the amino acids found between 
the two cysteines (Raina and Missiakas, 1997). Mutagenesis of the His-38 residue of 
PDI to Pro, makes this tetrapeptide sequence identical to thioredoxin, but results 
in a decrease in PDI activity (Lu et al., 1992). The active site in the a domain 
(PDIa) is located between beta sheet three and alpha helix four - as shown in figure
1.2. Both the a and a ’ domains are highly homologous to TRX protein of bacterial 
cells. A common feature shared with thioredoxin is the a lpha/beta  fold of the a 
domain with the structure of /3a/3al3(3a (Freedman et al., 2002). The most notable 
difference between these proteins is tha t TRX exists in the periplasm of bacterial 
cells and catalyzes reductive reactions suitable to the reducing environment of the 
cells, whereas PDI exists predominantly within the less reducing ER, catalyzing both 
oxidative and reductive reactions.
6
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DsbA C p H C E. coli
DsbB C V L C E. coli
DsbC c G Y c E. coli
DsbD c V A c E. coli
DsbE c P T c E. coli
Thioredoxin c G P c E. coli
PDI-a c G H c H. sapiens
Table 1.1: Members of the Thioredoxin Superfamily. A comparison of the active sites 
of 5 E. coli Dsb proteins, thioredoxin, and human PDI (Raina and Missiakas, 1997).
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
1.1.3 P D I Disulfide Bond Rearrangement
The enzymatic goal of PDI is to replace reactive disulfides of its substrate with 
less reactive ones. This is based on a trial and error process, in which three different 
types of reactions take place: isomerization, reduction, and oxidation. This begins 
with PDI forming a complex with the misfolded substrate, so th a t one of the disul­
fides is disrupted to create a free sulfhydryl in the substrate. From the intermediate 
formed, the reaction can proceed in three different directions (Gilbert, 1997). The 
enzyme can be displaced, and the same disulfide bond will re-form so tha t no re­
arrangement occurs. The second reaction tha t can occur involves an intermolecular 
reaction between another substrate disulfide with the substrate thiol, to form a newly 
folded protein. Lastly, the substrate can be reduced to the original disulfide and then 
oxidized to form a different disulfide. In the last process, the second cysteine in the 
active site of PDI acts like a timer in tha t it induces reduction of the substrate, if 
a complex does not rearrange within a certain time. In the pink pathway of figure
1.3, simple rearrangement of substrate disulfides takes place. In the blue pathway 
of figure 1.3, it was proposed tha t the second cysteine prevents PDI from becoming 
trapped, in which PDI could ‘escape’, and reduction follwed by reoxidation of the 
substrate disulfides take place in a more timely manner. In more recent studies, PDI 
has been found to be involved in other activities such as integrin-dependent adhesion 
(Lahav et al., 2000), and denitrosation of S-nitrosothiols (Zai et al., 1999).
8
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Figure 1.3: Disulfide rearrangement by PDI. A mechanism of disulfide rearrangement 
for PDI represents the different pathways tha t may occur during PDI- assisted protein 
folding (Schwaller et al., 2003).
9
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1.1.4 R edox Control of PD I A ctivity
PDI is an oxidative enzyme performing its reactions in the less reducing ER 
(Raina and Missiakas, 1997), compared to the reducing environment of the cytoplasm. 
Thiol content determination in PDI is assessed by titration with 5,5’-dithio-fc-3- 
nitrobenzoate (DTNB). Freshly reduced bovine PDI was revealed to contain 1 free 
sulfhydryl and 3 disulfide bonds (Gilbert, 1989), although the exact location of these 
groups are not specified. The environment inside the endoplasmic reticulum has been 
found to favour thermodynamically the formation of disulfide bonds by increasing 
protein stability in the organelle. The conditions of this environment are created by 
the relative concentrations of glutathione in its reduced and oxidized form, GSH and 
GSSG. In the cytoplasm of cells the [GSH] to [GSSG] ratio is (30-100): 1, whereas 
in the ER of cells, it is only 3:1 (Raina and Missiakas, 1997). This difference is 
im portant for PDI to stay in the predominantly reduced form, as its primary function 
is oxidation of proteins in disulfide bond formation. The active site of PDI contains a 
redox potential between -110 and -170 mV (Lundstrom and Holmgren, 1993). Outside 
of the ER, PDI is more likely to act as a reductant (Noiva, 1999).
1.1.5 P eptide Binding
PDI is able to act on a wide spectrum of substrates catalyzing thiol exchange 
reactions, and is largely dependent on its ability to bind to polypeptides. In this re­
spect, PDI has a less than 100 fiM, indicating a low affinity for peptides (Morjana 
and Gilbert, 1991). In 1999, Koivunen and coworkers identified a peptide binding 
site in PDI, separate from the active site, between residues 452-461 in the a ’ domain. 
Studies involving m utation or deletion of the b, b ’, and c domain show evidence to 
support tha t these domains are involved in peptide binding. M utation of the b ’ do­
main reduced isomerase activity (Darby and Creighton, 1998), and deletion of the c 
domain inhibited substrate binding activity (Dai and Wang, 1997). PDI exhibits in­
creased affinity for polypeptides tha t contain a higher content of Cys residues (Klappa 
et al, 1998), which correlates with its primary role in protein folding.
10
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1.1.6 Chaperone A ctivity
The true definition of a molecular chaperone is to “assist polypeptides to self- 
assemble by inhibiting alternative assembly pathways th a t produce non-functional 
structures” (www.Biology-Online.com 31/05/05). A well known molecular chaper­
one, GroEL/ES undergoes repeated cycles of folding and unfolding, until a more 
stable form of its substrate is attained (Todd et al, 1996). In the same respect, PDI 
is thought to undergo a similar process in the formation and exchange of disulfide 
bonds in proteins (Walker and Gilbert, 1997). Generally chaperones work to inhibit 
the aggregation of substrate molecules. PDI does this by rapidly forming disulfide 
bonds in its substrate, and using its peptide binding sites to help prevent aggregation 
(Quan et al., 1995). Ironically, depending on the concentration of PDI with respect 
to the substrate, PDI can act as an anti-chaperone in facilitating aggregation (Puig et 
al, 1994). For example, low concentrations of PDI (10 fiM) added to a solution of un­
folded and reduced lysozyme causes the formation of insoluble aggregates containing 
PDI and lysosyme, but when higher concentrations of PDI (100 //M) are added, ag­
gregation ceases (Goldberg et al, 1991). PDI makes up 1% of total cell protein, whose 
sheer concentration may also assist with the folding process by inhibiting aggregation 
of unfolded proteins.
1.1.7 Cell Surface P D I (csPDI)
PDI has shown to be very unique with respect to its functions in the cell. PDI 
has been found on the plasma membrane of platelets (Chen et al, 1995). This change 
in location suggests alternative functions of PDI. In lieu of the traditional activities of 
this protein in the ER, it has been involved in mediating integrin-dependent adhesion 
(Lahav et a l, 2000) and aggregation (Essex and Li, 1998) in blood platelets. Platelet 
adhesion is im portant for blood coagulation, and this adhesion pathway is mediated 
by adhesion receptor integrins. It is thought tha t there is disulfide exhange or free 
sulfhydryl participation on the integrins. Lahav and coworkers (2000) found tha t by 
blocking PDI activity, integrin adhesion is inhibited. Recent studies have also shown
11
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tha t csPDI also plays a role in nitric oxide release from S-nitrosothiols (Root et al., 
2004), which is discussed in section 1.1.9.
1.1.8 P D I K inetics
In 1989, Gilbert first proposed a mechanism for PDI catalyzed disulfide reduc­
tion. Since then, many studies examining the folding pathways of ribonuclease A 
(Shin et al, 2002), creatine kinase (Zhao et al, 2005), and alcohol dehydrogenase 
(Primm et al, 1996) have attem pted to delineate models of PDI activity. In the 1989 
study by Gilbert, a hexapeptide (CYIQNC) and reduced glutathione (GSH) were used 
to probe the kinetic mechanism of PDI. In this study, he examined the PDI-dependent 
production of GSSG coupled with the oxidation of GSH by PDI, with glutathione re­
ductase activity in the presence of excess NADPH. It was found th a t there were three 
separate phases of reduction of PDI disulfide bonds: slow (k=0.0019 min-1), medium 
(k==0.025 min-1), and fast (k=0.21 min-1) (figure. 1.4). The proposed mechanism 
is dependent on GSH concentration; elevating the GSH concentration results in an 
increase of the reduction of PDI. Unfortunately, kinetic obstacles in early experimen­
tation did not account for certain variables such as the auto-oxidation of GSH to 
GSSG, the non-enzymatic reaction between the two substrates, and the reduction of 
PDI by GSH. Taking these factors into account, a hybrid mechanism was proposed 
based on GSH concentration. More current models by Gilbert and colleagues propose 
an “escape” mechanism, in which disulfide isomerization involves cycles of reduction 
and reoxidation (Schwaller et al, 2003) (figure 1.3). This mechanism also suggests 
tha t at increased concentrations of GSH, the rate of isomerization is decreased because 
of competition with protein substrate oxidation (Schwaller et al, 2003). Although 
there are no proven enzyme models for PDI, because of the diverse array of substrates 
PDI can act upon, PDI may provide a number different options, depending on the 
substrate involved.
12
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Figure 1.4: PDI catalyzed disulfide reduction. The initial mechanism was proposed 
in 1989 by Gilbert, but had not accounted for kinetic obstacles.
13
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
1.1.9 D enitrosation A ctivity  of PD I
Nitric oxide (NO) is most commonly known for its role in smooth muscle re­
laxation (Bernal-Mizrachi et al., 2005), inhibition of platelet aggregation (Lincoln et 
al., 1990), and molecular signalling (Linden et al., 2005). S-nitrosothiols (RSNOs) 
are im portant transporters and donors of nitric oxides. Furthermore, RSNOs act as 
sinks for nitric oxide to prolong its half life, which varies inversely depending on its 
concentration in the cell. It has been shown tha t NO transfer from RSNOs is medi­
ated by csPDI (Zai et al, 1999). More recent work demonstrates the ability of PDI 
to store NO released from RSNOs, and denitrosate S-nitrosated PDI (PDI-SNO) at 
physiological pH (Sliskovic et al, 2005). The proposed mechanism for PDI denitro­
sation begins with the transnitrosation of the a subunit with RSNO, and leads to the 
production of an unstable NO' intermediate with an oxidized enzyme (figure. 1.5). 
Implications of this research demonstrate the importance of PDI in the movement of 
NO bound to RSNOs.
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Figure 1.5: Mechanism for PDI denitrosation. Mutus and coworkers (2005), proposed 
a denitrosation mechanism with the active site of the a domain in PDI undergoing a 
transnitrosation reaction. The intermediate formed is shown to be stabilized by the 
imidazole group of His387 (numbers used are in accordance with the sequence found 
in appendix A). The final products are an oxidized protein, and NO'.
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1.2 Apoptosis
In all living organisms, every cell exists for a finite amount of time, before it dies. 
Cell death can be suicidal, but the death of a few cells may aid in maintaining tissue 
homeostasis. Alternatively, cell death can be uncontrollable by internal cell function, 
as it is imposed by outside variables such as physical damage, toxic chemicals, extreme 
heat or pressure. Each type of cell death has different features and markers by which 
they are characterized. Cell death by suicide is often referred to as programmed 
cell death (PCD), or apoptosis, whereas death by injury is referred to as necrosis. 
The term  apoptosis was first coined in a 1972 paper by Kerr, Wyllie, and Currie 
with the pronounciation of a-poe-to-sis. Classical origins of this term  orginate from 
Hippocrates (460-370 B.C.) in which he first used the word to describe bone erosion 
in relation to tissue death (www.celldeath-apoptosis.org 31/05/05).
1.2.1 Features of Necrosis Versus A poptosis
Until the landmark study in 1972 by Kerr and colleagues, only necrotic cell death 
was studied. Damage to cells induced by traum a or damage causes cell swelling, 
membrane breakage, and release of lysosomal enzymes leading to inflammation dam­
aging nearby cells (Gores et al, 1990). Conversely, apoptosis is stimulated by internal 
mechanisms within the cell and is a highly orchestrated process. Apoptosis occurs 
during development, in the immune system, in the inflammatory response, and in 
aging (Duke et al., 1996). Death by suicide is characterized by cell shrinking and 
detachment, chromatin condensation, cytoplasmic membrane blebbing, the appear­
ance of apoptotic bodies, and phagocytosis of the apoptotic bodies by macrophages 
(Kerr et al, 1972) (figure. 1.6). Biochemical features include protein cleavage by 
caspases, and the expression of surface markers on apoptotic cells (Nagata, 2000). 
A prominent biochemical feature which distinguishes necrosis from apoptosis is the 
DNA fragmentation found in apoptosis, which is visualized as a ladder on an agarose 
gel. In necrosis, cell death can be almost instantaneous, in which the DNA remains 
undamaged, and this is indicated by a smear on an agarose gel.
16
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Figure 1.6: Necrosis vs. Apoptosis. The pathway to the left demonstrates cellular 
features of the necrotic pathway. The right side of the figure shows morphological 
features of apoptosis (Pollack and Leeuwenburgh, 2001).
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1.3 The Biochemical Mechanism of Apoptosis
Cell death can be initiated through four different mechanisms: receptor-mediated 
apoptosis, growth factor deprivation, oxidative stress, and gen otox ic  exposure. O nce 
the pathway has begun, it can be divided into four different stages of progression 
(Hengartner, 2000). Apoptosis begins with a receptor or non-receptor mediated death 
signal, which signals the nucleus to initiate a suicide reponse. This is followed by a 
control and integration stage in which there is signal transduction, transcription factor 
activation, and ATP depletion. In the execution stage, cell death be carried out in 
two different pathways; a death receptor pathway (Ashkenazi and Dixit, 1998), or a 
mitochondrial pathway (Tatton and Olanow, 1999). Once these pathways have been 
initiated, the DNA degradation stage begins, and the cell begins to shrink and bleb, 
expressing phagocyte recognition molecules. In the final stage, phagocytosis occurs, 
removing dead cells and their debris (figure 1.6).
1.3.1 The D eath  R eceptor Pathway
In the death receptor pathway, the binding of a ligand to a cell surface death 
receptor mediates a downstream death signal (Hengartner, 2000). These receptors 
belong to the tum or necrosis factor receptor (TNF) family. CD95 (also known as 
Fas or A pol), a member of the TNF superfamily (SCOP 49599, CATH 2.60.210.10) 
(Murzin et al., 1995, Pearl et al, 2005), contains a characteristic cysteine-rich extra­
cellular domain (Smith et al., 1994), and a cytoplasmic “death domain” (Tartaglia 
et al., 1993). Binding of a CD95 ligand (CD95L) to the CD95 receptor leads to 
the association of the death domains, and the binding of an adapter protein termed 
FADD (Fas-associated death domain) (figure 1.7). FADD contains a “death effec­
tor domain” which binds inactive caspase-8 (also known as FLICE or MACH). Once 
bound, the oligomerization of caspase-8 initiates self-cleavage, and activation of other 
caspases (Ashkenazi and Dixit, 1998). These caspases belong to a family of cysteine 
specific proteases (Thornberry and Yuri, 1998), which cleave peptide bonds at the 
carboxyl terminal side of aspartic acid residues (Villa et al., 1997). There are many
18
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other receptors and pathways tha t have been shown to be involved in either initiating 
or protecting against apoptosis. The example of the CD95 mediated pathway has 
been shown to play a pivotal role in a different type of apoptosis (Nagata, 1997). 
These types include inflammatory cell death at “immune-privileged sites” , virus or 
cancer-infected cell death by cytotoxic T  and natural killer cells, and the deletion of 
activated m ature T  cells at the end of an immune response (Nagata, 1997).
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Figure 1.7: Apoptotic signalling through a death receptor pathway. Outside of the 
cell, CD95L binds to the CD95 trimeric receptor. Inside, adaptor protein FADD 
associates with the death domains of the CD95 receptor. Inactive caspase-8 then 
binds through the death effector domain of FADD, which initiates self-cleavage of 
caspase-8. This leads to the activation of other downstream caspases (Adapted from 
Ashkenazi and Dixit, 1998).
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1.3.2 The M itochondrial Pathway
Mitochondria have been shown to play a very critical role in the apoptotic 
process. The disruption of the mitochondrial membrane potential (A ip) across the 
inner membrane causes the leakage of cytochrome c, apoptosis initiating factor (AIF), 
and caspase-9 into the cytoplasm (Kroemer et al., 1997). These three factors together 
form an apoptosome, which leads to the activation of downstream caspases involved 
in the execution stage of apoptosis (figure 1.8). Although it is still not clear as to how 
they are released from the mitochondria, it is believed th a t following a decrease in 
mitochondrial membrane potential, a permeability transition pore (PTP) is opened 
in which cyt-c and other mitochondrial proteins are released (Tatton and Olanow, 
1999). Mitochondria are the central location for oxidative phosphorylation, and the 
largest producer of reactive oxygen species (ROS) in the cell. Once disrupted, ROS 
are generated, and are highly reactive and cytotoxic to the cells (Betteridge, 2000). 
ROS has been have been shown to target mitochondrial DNA (Shoji et al, 1995), 
mediate apoptosis (Kamata and Hirata, 1999), and even increase the prevalence of 
cancer in those individuals exposed to oxidative stress (M arnett, 2000).
21
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Figure 1.8: A hypothetical model of apoptotic initiation through the mitochondrial 
pathway. Following a decrease in mitochondrial membrane potential, a permeability 
transition pore (dark ovals) opens and cyt-c and AIF are released into the cytoplasm. 
By their associating with caspase-9, an apoptosome is formed, and downstream cas­
pases are activated (Modified from Nomura, 2004).
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1.3.3 P D I as a N europrotective Protein
In a 2000 study, Tanaka and coworkers identified a stress protein up-regulated 
in response to hypoxia in glial cells. This protein was identified as PDI, and they 
found tha t its overexpression in primary cultured glial cells significantly reduced the 
loss of cell viability, when subjected to hypoxia. In the same study, Tanaka overex­
pressed PDI in different regions of rat brain and subjected them  to ischemia. They 
observed tha t overexpression of PDI could suppress ischemia-induced apoptosis in 
the transfected area. PDI has been examined in conjunction with Alzheimer’s dis­
ease (AD), which is characterized by the presence of neurofibrillary tangles, plaques, 
and degeneration of nerve cells (Corder et al., 1993). During the development of 
Alzheimer’s disease, it was noticed tha t during the shift in the redox balance of cells, 
there was no increase in PDI (Kim et al, 2000). These scientists have postulated 
tha t the high levels of PDI tha t are found in neurons help to maintain the redox bal­
ance, but further oxidative damage may take place, because the concentration of the 
protein remains the same. Interestingly enough, PDI was found to be overexpressed 
in the brains of individuals with Creutzfeldt-Jakob disease (CJD) (Yoo et al, 2002). 
More importantly, they were able to distinguish tha t PDI did not assist with the 
conformational change of the prion protein to a diseased form. Since the finding by 
Tanaka and coworkers in 2000, another protein tha t associates with PDI during cell 
death has been identified. Ubiquilin, which contains a ubiquitin-like domain and a 
ubiquitin-associated domain, are up-regulated during hypoxia in a similar time frame 
as PDI (Ko et al, 2002). Furthermore, ubiquilin is up-regulated in neurons of AD 
patients in association with the neurofibrillary tangles (Mah et al, 2000).
Apoptosis is a physiological requirement for the development and maintainence 
of tissue homeostasis. Disruption of this process, in which pathways become uncon­
trollable can result in diseases, in which there can be massive cell death, or no cell 
death at all. These include diseases such as Alzheimer’s disease, Parkinson’s dis­
ease, strokes, AIDS, auto-immune diseases, and cancers. In another example, PDI 
was characterized as a negative regulator of NF-reB, which is a transcription factor
23
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that induces an inflammatory response with acute and chronic immune and regener­
ation disorders (Higuchi et al., 2004). It is im portant to continue to study PDI and 
understand completely the many ways in which this multifaceted protein functions.
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Chapter 2
Development, Expression, and 
Localization of PD I and its Active 
Site Domain
2.1 Objectives
Although PDI makes up approximately 1% of total protein content in cells 
(Goldberger et al., 1964), an accessible source of human PDI is generally desirable 
for experimental studies and assays. Research to study the S-denitrosation activity 
of PDI (Sliskovic et al., 2004), S-nitrosoglutathione consumption mediated by PDI 
(Root, et al., 2004), and the development of more sensitive assays for the protein, 
required a readily attainable source of human PDI. To make this available, human 
PDI cDNA was cloned into the bacterial vector pET-28b containing two histidine tags 
(at the N-terminus and C-terminus) - see Appendix B. The vector was transformed 
into BL21(DE3) E. coli cells for simple purification of the recombinant protein through 
Ni2+ affinity chromatography. Also to isolate the source of activity in the protein for 
future study, the active site a domain was separately cloned into the pET-28b vector 
for further investigation on its copper binding abilities.
Characteristic of many ER resident proteins, PDI also contains the KDEL signal
25
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retention sequence. Although found predominantly in the ER, different isozymes of 
PDI have been identified in various cell types, which are not localized to the ER. To 
visualize the localization of PDI within neuroblastoma cells, human PDI cDNA was 
fused to green fluorescent protein in the pEG FP-N l vector (Clontech), and transfected 
into SH-SY5Y cells. Differentiation of these cells further resolved its locale within 
this cell type. PDI, being a redox protein is readily influenced by its environment. 
Because PDI is well established as an ER protein, its localization outside of the ER 
is examined.
2.2 Materials and M ethods
2.2.1 Chem icals, Biochem icals, and Supplies
•  Bis-Acrylamide solutions were purchased from Bio-Rad Laboratories (Missis­
sauga, ON).
•  Restriction endonuclease EcoRl, Taq polymerase, direct load wide range DNA 
marker, direct load wide molecular weight range protein markers, low molecular 
weight range protein marker, ultra-low molecular weight range protein markers, 
high capacity nickel chelate affinity m atrix (Ni-CAM HC RESIN), ampicillin, 
kanamycin, ribonuclease A (RNase), deoxyribonuclease I (DNase I), lysozyme, 
isopropyl/3-D-thiogalactoside (IPTG), agarose, ammonium persulfate, brilliant 
blue R, calcium chloride, ethylenediaminetetraacetic acid (EDTA), glycine, im­
idazole, magnesium chloride hexahydrate, potassium acetate, potassium phos­
phate, sodium azide, phenylmethyl sulfonyl fluoride (PMSF), sodium chloride, 
trizm a base, urea, tryptone, thiamine, tricine, zinc chloride, guanidine hy­
drochloride, protease inhibitor cocktail and 3’,3’,5’,5’-tetramethylbenzidine were 
purchased from Sigma Aldrich (Oakville, ON).
•  Restriction endonucleases H indlll, PstI, Kpnl, Xhol, and T4 DNA Ligase were 
purchased from Promega Corporation (Madison, WI).
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• Taq Polymerase was kindly donated by Dr. S. Ananvoranich.
• Oligonucleotides were ordered from Sigma Genosys (Oakville, ON).
•  1 ml tubes were stored in CryoBoxes which were then stored in CryoBox vertical 
racks from Nalgene (Rochester, NY).
» Phenol:Chloroform:Isoamyl Alcohol (25:24:1) was purchased from Invitrogen 
Life Technologies (Burlington, ON).
• P2, P10, P20, P200, P1000, P5000 Pipetmen from Gilson were supplied by 
Mandel Scientific Company Inc. (Villiers-le-Bel, France).
•  Plasmid Midi Kit, QIAquick PCR Purification Kit and QIAquick Gel Extraction 
Kit were purchased from Qiagen (Mississauga, ON).
« Yeast extract and granulated agar were purchased from Becton Dickinson and 
Company (MD).
•  Ammonium chloride, disodium hydrogen orthophosphate heptahydrate, glyc­
erol, magnesium sulphate, potassium chloride, sodium dihydrogen orthophos­
phate, sucrose, sodium hydroxide and D-glucose were purchased from BDH Inc.
• Amicon Ultrafiltration devices, 10K MWCO (15 ml) were purchased from Mil- 
lipore (Bedford, MA).
• FuGene 6 transfection reagent was purchased from Roche Diagnostics (Laval, 
QB).
•  Hoechst Dye 33342, Mitotracker Red 580, Annexin V 594 (Molecular Probes, 
USA), and Brain Derived Neurotropic Factor (Alomone Labs, Israel) were kindly 
obtained from Dr. S. Pandey.
• Geneticin G418 was purchased from Gibco (Burlington, ON).
• Polyclonal rabbit anti-PDI antibody was purchased from Abeam (Cambridge, 
MA).
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• Anti-goat horseradish peroxidase antibody was kindly obtained from Dr. B. 
Mutus.
2.2.2 Bacterial Strains and Plasm ids
• pET 28b (Novagen).
• pET 11a (Novagen) containing PDI cDNA was kindly obtained from Dr. B. 
Mutus. It was a gift from X. Jiang.
• pEG FP-N l (Clontech).
•  BL21(DE3) E.coli cells (Invitrogen Life Technologies).
2.2.3 Apparatus and Instrum entation
•  Acrylamide gels were cast on a Hoefer Mighty Small SE 245 Dual Gel Caster, 
and acrylamide gel electrophoresis was conducted using a Hoefer Mighty Small 
II SE 250 Mini-Vertical Gel Electrophoresis Unit, both from Amersham Phar­
macia Biotech (Laval, QB).
• Agarose was melted in a 0.6 cubic foot microwave oven from Magnasonic (ON, 
C anada).
• Gel casting and agarose gel electrophoresis were conducted in a Horizon 58 
Horizontal Gel Electrophoresis Apparatus from Gibco BRL Life Technologies 
(Burlington, ON).
• Samples were weighed on a Mettler AE50 scale from Cambridge Scientific (MA, 
USA).
•  Larger samples were weighed on a Ohaus Compact scale from Ohaus Corpora­
tion (NJ, USA).
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• Agarose gels stained with ethidium bromide were viewed and photographed on 
the Alphalmager 2200 Light Imaging System with AlphaEase software from 
Alpha Innotech Corporation (San Leadro, CA).
• Agarose gels stained with ethidium bromide were viewed using the Benchtop 
Ultraviolet Transilluminator from VWR Scientific (ON, Canada).
• The Agilent 8453 UV-visible spectrophotometer from Agilent Technologies (ON, 
Canada) was used to measure protein concentration, enzyme activity, and cell 
culture growth and density.
•  Polymerase Chain Reactions (PCR) were carried out in a 48-well Perkin Elmer 
Cetus DNA thermal cycler from Perkin Elmer, (CT, USA).
• Centrifugations were performed using an Fisher Model 59A microcentrifuge 
from Fisher Scientific (ON, Canada).
• pH measurement of buffers and solutions were done using pH Meter Model 420A 
by ORION (ON, Canada).
• Insulin turbidity assay was measured on the Ultra Microplate ELx808/[/ from 
BIO-TEK Instruments, Inc. (VT, USA).
•  Incubations at 37°C with agitation were done in the C25 Incubator Shaker 
Classic Series by New Brunswick Scientific Co., Inc.
• Cell lysis was performed using the Sonic Dismembrator Model 100 from Fisher 
Scientific (ON, Canada).
• Bacteria grown on agar plates were incubated in the Model 1510E Incubator by 
VWR Scientific (ON, Canada).
• Heating and boiling of protein samples were in the Canlab block heater by 
American Hospital Supply Canada Inc.
• All microscopy was performed on the Leica DM IRB Microscope from Leica 
Microsystems (Germany).
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• All pictures were taken using a Qlmaging camera.
•  DCFDA fluorescence was measured with the Spectra Max Gemini XS multi-well 
plate fluorescence reader (CA, USA).
• Centrifugation was performed on a J2-HS Beckman centrifuge with JA-10, JA- 
14, and JA-20 rotors.
•  Ischemic conditions were simulated with the Gas Pack System from Becton 
Dickenson (Cockeysville, MD).
• Dessication of protein was done in the Labconco Model 4451F Lyophilizer, 
Labquip Limited (Markham, ON).
• DNA sequencing was performed at Wayne State University DNA Sequencing 
facility.
2.2.4 Cell Lines and M edia
Human umbilical vein endothelial cells (HUVEC) were purchased from the 
American Type Culture Collection (ATCC), and were maintained in Kaighn’s F12K 
medium (Gibco, Canada) containing 1.5 g/L  sodium bicarbonate, 2 mM L-glutamine, 
and supplemented with 0.1 mg/ml heparin (Sigma, Canada), 10% fetal bovine serum 
(Gibco, Canada), and 0.03-0.05 mg/ml endothelial cell growth supplement (BD Bio­
sciences, USA). Human Neuroblastoma (SH-SY5Y) cells were also purchased from 
ATCC, and maintained in Dulbecco’s Modified Eagle Medium Ham ’s F12 media 
(Sigma, Canada) containing 1.5 g/L  sodium bicarbonate, and supplemented with 
10%i fetal bovine serum (Gibco, Canada), and 2 mM L-glutamine (Gibco, Canada).
2.2.5 General D econtam ination and Sterilization Procedures
All glassware, pipette tips, centrifuge tubes, and Milli-Q water used for both 
bacterial and mammalian cell culture were autoclaved to avoid bacterial and fungal 
contamination. All supplies used in the cell culture laminar flow hood were sprayed
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with 70% ethanol. The laminar flow hood was sterilized each day with an ultraviolet 
lamp.
2.3 Protein and Bacterial Work
2.3.1 P D I cD N A  Expression Cloning in Bacterial Cells
The plasmid vector p E T -lla  containing PDI cDNA, was verified by sequencing 
prior to use for cloning. An expression construct was derived using Taq polymerase 
and primers (forward 5-AAAGAATTCAGACGCCCCCGAGGAGGAGGAC-3; re­
verse 5-CCCAGGCTTCAGTTCATCTTTCACAGCTTTCTGATC-3) which brack­
eted the open reading frame of PDI cDNA and possessed restriction sites for Eco R I  
and Hind III, respectively, to facilitate insertion into pET-28b. Primers were gen­
erated by Sigma Genosys and designed by the custom created computer program 
written by R. Nistor and D. Seslija found in Appendix C. Polymerase chain reaction 
was carried out in a to tal volume of 100 fA, containing 20 mM ammonium sulfate, 75 
mM Tris-HCl (pH 8.8), 5 mM MgCl2 , 20 fiM of each dNTP, 50 pmol of each primer, 
500 ng of p E T -lla  template, and 2 units of Taq DNA polymerase. PCR was run for 
30 cycles (95°C for 60 seconds, 55°C for 30 seconds, 72°C for 80 seconds. Samples 
were stored at 4°C until further use (Gibbs, 1990). The insert and vector were ligated 
together using T4 DNA ligase, according to directions by Promega. The construct 
was transformed into E. coli strain BL21(DE3) using the calcium chloride protocol 
(Sambrook et al., 1989) and grown on agar plates containing 10 m g/L of kanamycin. 
The presence of PDI cDNA insert in bacterial cells was then verified by screening 
colonies from the plates, followed by plasmid extraction (Novagen pET manual pro­
tocol) and digestion with the restriction enzymes EcoRI and H indlll. The restriction 
digest was analyzed on a 1.5% agarose gel (Sambrook et al., 1989). Wayne State 
University DNA Sequencing facility verified the presence of the fusion product.
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2.3.2 P D Ia cD N A  Expression Cloning in Bacterial Cells
An expression construct was derived using Taq polymerase and primers (forward 
5-AAAGAATTCAGACGCCCCCGAGGAGGAGGACCACGTCCTG-3; reverse 5-TT 
TAAGCTTGGCAGCCGGGCCCGTGCGCTTCTTCAGCCA-3) which bracketed the 
open reading frame of the active site a domain (PDI-a), and possessed restriction sites 
for EcoRI and H indlll, respectively, to facilitate insertion into pET-28b (refer to Ap­
pendix B). Primer construct and PCR were done as described in section 2.3.1. The 
insert and vector were ligated and transformed into E. coli BL21(DE3). Cells were 
maintained on agar plates containing 10 mg/1 kanamycin plates. The presence of the 
a-domain was verified by sequencing at the Wayne State University DNA sequencing 
facility.
2.3.3 Purification of the Recombinant Proteins
Bacterial cultures containing the recombinant plasmid were induced with 1 mM 
IPTG overnight at room temperature. Cultures were centrifuged at 6  000 rpm in a 
JA-10 rotor for 20 minutes at 4°C and the supernatant was discarded. The pellet 
was resuspended in cell lysis buffer (3 m l/g of pellet). Lysozyme was added to the 
suspension to a final concentration of 0.3 m g/m l and shaken at 4°C for 30 min. 
Sodium deoxycholate (1 mg/ml), DNase I (6.7 mg/L), and RNase (6.7 mg/L) were 
added to the lysate and shaken at 37°C for 20 minutes, until the mixture was no 
longer viscous. The cell suspension was sonicated 3 times for 30 seconds at level 7.5 
on the Sonic Dismembrator, and the mixture was then centrifuged at 15 000 rpm on a 
JA-20 rotor for 20 min at 4°C. The pellet was kept on ice, while the supernatant was 
added to the nickel column. The recombinant fusion protein was isolated using nickel 
affinity chromatography. All steps were performed at 4°C unless otherwise stated. 
Prior to loading the crude extract, 1.5 ml of nickel resin suspension was prepared 
according to the Sigma product manual protocol. The crude extract was then shaken 
gently at 4°C for 30 minutes. The crude extract-resin mixture was then packed into a 
20 ml polypropylene column and loaded at a flow rate of 1 ml/min. The flow through
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was collected and reserved for SDS-PAGE. The resin was then washed with 30 ml 
of 10 mM imidazole wash buffer or until the optical density (OD) measured at 595 
nm was comparable to the blank. The resin was then washed with 30 ml of 30 mM 
imidazole, or until the OD595 was similar to the blank. Further non-specifically bound 
proteins were washed with 10 ml of 100 mM imidazole, and finally, the target protein 
was eluted within the first 4 ml of 250 mM imidazole elution. The eluted protein was 
collected in 1 ml fractions, and its concentration was determined using the Bradford 
reagent. To confirm the presence of the isolated his-tagged protein, PDI, and PDI-a 
were analysed together on a 13.5% SDS-PAGE and then stained with Coomassie blue.
2.3.4 Im m unoblot Analysis
Purified recombinant protein was run on a 13.5% SDS-PAGE gel, and elec- 
trophoretically transferred to nitrocellulose membrane using transfer buffer (2 0 % 
methanol, 24 mM tris base, 0.2 M glycine)(Sambrook et al, 1989). After transfer, 
the blot was temporarily stained with a 1:9 dilution of Ponceau S for 10 minutes, 
and washed with water. The blot was placed in Tris Buffered Saline (TBS - 0.02 M 
Tris HCL, 0.2 M NaCl, pH 8.2) solution with 5% skim milk for 2 hours at room 
temperature, to block non-specific binding sites on the membrane. Incubation with 
primary polyclonal rabbit anti-PDI antibodies at a 1:1000 dilution in TBS with 2% 
skim milk was done overnight at 4°C. The membrane was then washed with TBS 
twice for 10 minutes. For detection of polyclonal anti-PDI antibody, the membrane 
was incubated with the secondary antibody horseradish peroxidase anti-goat IgG at 
a 1:2000 dilution in TBS with 2% skim milk at 4°C for 2 hours. The membrane was 
then washed for 30 minutes with TBS. Visualization was performed by adding 5 ml 
of 3’,3’,5’,5’-Tetramethylbenzidine producing a permanent blue reaction product.
2.3.5 Insulin Turbidity Assay
To test the activity of both recombinant proteins, the experiment described by 
Holmgren (1979) was modified for a 96-well plate. 4 mM DTT, 2 / jM  enzyme sample,
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and 1 mM insulin were added to the assay buffer (0.1 M K 2HPO 4 , 2 mM EDTA, pH 
7.0) to a volume of 200 fil. Absorbance was monitered using the kinetics mode at 650 
nm at 0.5 minute intervals for 30-45 minutes.
2.3.6 P D I cD N A  Expression Cloning in Bacterial Cells for 
M am m alian Expression
An expression vector for protein localization was derived using Taq polymerase 
and forward primers 5-AAAAGAATTCTTATGGACGCCCCCGAGGAGGACGAC- 
3; reverse primer 5-AAATGGTACCTGCAGTTCATCTTTCACAGCTTTCTGATC- 
3) which bracketed the open reading frame of the PDI cDNA, and possessed restric­
tion sites for Eco R I  and Kpn I, respectively, to facilitate insertion into pEG FP-N l 
(refer to Appendix B). The insert and vector were ligated and transformed into E. 
coli BL21(DE3) as described previously in section 2.3.1. Cells were maintained on 
agar plates containing 10 m g/L kanamycin. The construct was also verified through 
sequencing by Wayne State University DNA Sequencing facility.
2.3.7 H U V EC  Transient Transfection
A standard protocol for calcium phosphate-mediated transfection (Sambrook et 
al., 1989) was performed on the HUVECs. Plasmids pEG FP-N l and PDI:pEG FP-N l 
were prepared using the Qiagen midiprep kit, and DNA concentration and purity were 
measured at an absorbance of 260 nm and 280 nm (Glasel, 1995). Visualization of 
the plasmid DNA was executed on a 1.5% agarose gel. HUVEC transfection was also 
attem pted using FuGENE 6  transfection reagent, according to the manufacturer’s 
protocol (Roche Diagnostics).
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2.3.8 In Vitro Transfection by a Liposomal reagent in SH- 
SY 5Y  Cells
FuGENE 6  transfection reagent was used to transfect SH-SY5Y cells, according 
to the manufacturer’s protocol (Roche Diagnostics). pEG FP-N l and PDI:pEGFP-N l 
plasmids were prepared using the Qiagen midiprep kit, and DNA concentration and 
purity was measured as described in section 2.3.7. Success of transfection was verified 
by observation of the green fluorescence of cells under a UV lamp with a GFP filter.
2.3.9 D eterm ination of G418 Sensitivity on SH -SY 5Y  Cells
A set of eight (35 mm 2 x 10mm2) plates were prepared by splitting a confluent 
25 mm 2 flask so the cells were 25% confluent in 24 hours. The next day the culture 
medium was replaced with medium containing varying concentrations of G418 (0, 
50, 150, 2 0 0 , 300, 400, 500, 800 Aig/ml G418). G418 was used to select against cells 
that did not contain the pEG FP-N l plasmid. The selective media was changed every 
48 hours, and the percentage of surviving cells was observed. The concentration of 
antibiotic G418 th a t prevented cell growth within two weeks was chosen (Tzen et al, 
1990).
2.3.10 G eneration of a Stable Cell Line in SH -SY 5Y  Cells
Two sets of SH-SY5Y cells were transfected with either pEG FP-N l plasmid, 
or PD I:pEG FP-N l plasmid. Forty-eight hours post transfection, the cells were split 
into a 1:3 ratio, with medium containing the 200 /jg/ml of G418. The cells were fed 
with selective medium every 48 hours for one week, until colonies of stable cells were 
identified with fluorescent microscopy. Cells were then transferred into 24-well plates 
for growth and expansion.
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2.3.11 Effect of Coenzym e Qi0 (CoQ i0) on Improving the  
Lifetim e of Stable Cells
Following the generation of stable cell lines, cells were lifted from the 24-well 
plate, and transferred to 35 mm2 x 1 0 mm2 plates. 1 /d of CoQio (50 mg/ml) was 
added for each millilitre of media, for half of the plates. Cells were examined for 
vitality and the absence of senescent cells, in comparison to those plates without 
CoQio-
2.3.12 Preparation of the Total Cell Lysate
Following experimental assays, the cells were washed twice with 1 X PBS, pH 
7.4, and then incubated at 4°C with TNTE buffer (0.5% Triton X, 150 mM NaCl, 50 
mM Tris, pH 7.5, 1 mM EDTA) for 15 minutes. Cells were harvested by mechanical 
dislodging with a rubber policeman, and the lysate was spun at 5 000 rpm in a JA-20 
rotor for 5 minutes. The supernatant was removed, and the pellet was resuspended 
in 200 pi of TN TE buffer containing 10 pi of protease inhibitor cocktail (prepared 
as described in the Sigma product information). The concentration of the total cell 
lysate was estimated using the Bradford reagent at an absorbance of 595 nm.
2.3.13 Im m unoprecipitation
Cells were lysed as described previously (section 2.3.12), and the concentration 
of protein used was 1 mg/ml. Polyclonal rabbit anti-PDI antibodies were added to 
the total cell lysate to a dilution of 1:100. The mixture was incubated on ice for 
two hours. Approximately 50 pi of Protein A agarose beads were added for every 
200 /A of cell lysate, and the solutions were rocked at 4°C for two hours. The beads 
were collected by microcentrifugation at maximum speed and washed three times 
with 1 ml of TN T buffer (same as TNTE minus the EDTA). The supernantant was 
removed, and the beads were resuspended in 50 pi of 2X loading buffer, and boiled for 
5 minutes at 100°C. Products were loaded onto a 10% SDS-PAGE gel, and subjected 
to a Western blot.
36
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
2.3.14 SH -SY 5Y  Differentiation
Differentiation of SH-SY5Y cells were carried out using a previously described 
method (Encinas et al., 2000). Cells were plated in 35 mm 2 petri plates, pre-coated 
with 0.05% collagen. Twenty-four hours later, all-trans retinoic acid was added to a 
final concentration of 10 /dVf, in F12 medium containing 15% Fetal Bovine Serum for 
5 days. Following, the cells were washed twice with F12 medium and incubated with 
50 ng/m l Brain Derived Neurotropic Factor (BDNF) in serum free media for seven 
days.
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2.4 Results
2.4.1 D evelopm ent and Expression of P D I in Bacteria
To clone the sequence of full length PDI (approximately 1490 nucleotides) into 
pET-28b, amplification of the human PDI cDNA sequence was performed from the 
p E T -lla  vector containing PDI cDNA, using PCR with primers flanking the cDNA 
sequence of PDI (figure 2.1). Bands of approximately 1.5 Kilobases (Kb) were iden­
tified to be amplified PDI cDNA. Two bands of 0.38 Kb and 0.05 Kb were found and 
indicate non-specific primer binding, due to the identical sequences of the a and a’ 
domain. Annealing temperatures of 55°C (lane 2) and 60°C (lane 3) were used in the 
PCR reactions. There was no major difference in PCR product with the five degree 
temperature differential. PCR cDNA from lane 3, at a molecular weight of 1.5 Kb, 
was used for ligation to the pET-28b vector.
Following ligation of the insert to the vector, colony screening and restriction 
enzyme digestion was done with EcoRI and Hindlll. The band observed at 1.5 Kb 
indicated the presence of PDI cDNA in the pET-28b vector (lane 4 - figure 2.2). The 
5.4 Kb band in lane 4 of figure 2.2 was the pET-28b plasmid. Lane 2 indicates the 
molecular weight of pET-28b plasmid, which is 5.4 Kb. Bands located higher than 
the molecular weight ladder indicate a linear conformation of the plasmid, as opposed 
to its coiled or supercoiled forms which migrate more easily through the gel. Lane 
3 indicates the the observed molecular weight of the ligated pET-28b:PDI plasmid 
which is 6.9 Kb. The digested pET-28b:PDI plasmid in lane 4 clearly indicates the 
molecular weight of the cDNA as 1.5 Kb.
The sequence of the reading frame from the 1.5 Kb piece of DNA of the recom­
binant plasmid was aligned with the cDNA sequence originally obtained from the 
pET-1 la:PD I plasmid,and GenBank accession number E03087 (human PDI) giving 
99.8% sequence identity. Base pair differences were due to the lack of identification 
of some base pairs, due to signal weakness, and lack of base pair identification in 
the chromatograph obtained from the Wayne State sequencing facility. The DNA 
sequence was consistent with the correct protein sequence.
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Similarity, cDNA amplification specific to the a domain (approximately 380 nu­
cleotides) of PDI yielded bands of 0.38 Kb (figure 2.3). Again, non-specific primer 
binding was present in both lanes, as indicated by the additional bands found at 0.05 
Kb. Colony screening and restriction enzyme digestion showed the presence of the 
0.38 Kb insert in the pET-28b vector (lane 2 - figure 2.4). Sequence identity between 
the a domain and full length PDI yielded 99.3% identity. Base pair differences were 
due to the lack of identification of some base pairs, due to signal weakness in the 
chromatograph obtained from the Wayne State sequencing facility.
Expression of each recombinant protein yielded approximately 1 8 - 25  mg of pro­
tein per 1 litre of bacterial culture. The presence of full-length PDI and PDIa protein 
were visualized by bands of approximately 6 6  KDa, and 19 KDa respectively (lane 7 - 
figure 2.5, lane 6  - figure 2.6). The increase in molecular weight by approximately 9.5 
KDa of both recombinant proteins was due to the presence of both an N-terminal and 
C-terminal His6 tags. Removal of the N-terminal His-tag would theoretically result 
in molecular weights of 61 KDa for full length PDI, and 14 KDa for the active site 
domain.
A Western blot further confirmed the presence of PDI and PDIa (lanes 1 and 2 - 
figures 2.7 and 2.8). Repeated detection of a weak band at twice the molecular weight 
(132 KDa) of full-length PDI agrees with the assumption of native PDI existing as a 
homodimer (Noiva, 1999). The insulin turbidity assay (figure 2.9) indicates tha t the 
activity of the full-length recombinant PDI is comparable to th a t of Sigma bovine 
PDI; the activity of the a domain showed comparable results, based on its capacity as 
a single domain. Removal of the N-terminal His6 tag through cleavage with thrombin, 
but its removal was found to have no effect on the activity of the protein (data not 
shown).
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2.4.2 D evelopm ent, Expression, and Localization of P D I in 
SH -SY 5Y  Cells
To develop a live cell reporter protein system  co n stitu tiv c ly  expressing PDI, N- 
terminal fusion of full-length human PDI to GFP was done using vector pEG FP-N l 
(Clontech). Using primers flanking full-length PDI, PCR was used to amplify its 
sequence from the p E T -lla  vector (lane 2 - figure 2.10). A band of approximately 1.5 
Kb was identified to be PDI cDNA. Bands found at 0.38 Kb and 0.05 Kb were again 
considered to result from non-specific primer binding. Following ligation of the 1.5 
Kb insert to the pEG FP-N l vector, colony screening followed by restriction enzyme 
digest with enzymes EcoRl and Kpnl, indicated the presence of the 1.5 Kb full length 
PDI cDNA within the vector (lane 4 - figure 2.11). Sequence alignment of the ex­
perimentally determined reading frame from this recombinant plasmid was compared 
with the cDNA sequence obtained from the pE T -lla :P D I plasmid, giving a 97.6% 
sequence identity. Base pair differences were due to the lack of identification of some 
base pairs, due to signal weakness in the chromatograph obtained from the Wayne 
State sequencing facility. There was no noticeable effect on the protein sequence.
HUVEC cells were chosen initially chosen as the target of mammalian cell trans­
fection, based on their role in nitric oxide transport. However, attem pts using both 
calcium phosphate, and liposomal (FuGene) mediated transfection were unsuccessful, 
based on the transfection efficiency of this particular cell type. Instead, transient 
and stable cell lines of SH-SY5Y neuroblastoma cells were generated using FuGene 6  
transfection reagent. Cells were maintained at a concentration of 200 pg/m l of G418, 
and it was found tha t the addition of 0.05 m g/m l of CoQio had no noticeable effects on 
reducing the number of senescent cells after 10 population doublings. Presence of the 
reporter protein in SH-SY5Y cells was verified by immunoprecipitation (figure 2.12). 
The molecular weight of GFP alone is approximately 27 KDa, and the molecular 
weight of PDI alone is approximately 57 KDa, together, with the presence of a small 
linker region between the two proteins, yields a molecular weight of approximately 
87 KDa. The 87 KDa band visible in lane one of figure 2.12 shows the presence of
40
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
the PDLGFP reporter protein in the transfected cells. The band at approximately 
57 kDa identifies the endogenous level of PDI found in the cells. Protein localization 
of PDI was examined in a stable cell line of differentiated SH-SY5Y cells. Cells were 
observed for areas of green fluorescence, which was found throughout the cell, includ­
ing the cytoplasm and dendrites (figure 2.13). Green fluorescence was also observed 
within the nucleus, and arrows indicate the absence of PDLGFP in the nucleoli of 
the cells.
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2.5 Discussion
The study of protein structure and function has been greatly aided by the de­
velopment of systems th a t are able to regulate protein expression. More specifically, 
recombinant protein systems allow for the controlled expression of copious amounts 
of proteins, otherwise too difficult to obtain from their natural in vivo conditions. 
Full-length PDI and its active site domain were produced in E. coli as soluble pro­
teins, with the addition of 2 Hisg tags located at the N and C-termini of each protein, 
to aid in purification. The isolated recombinant full-length PDI exhibited enzymatic 
activity similar to commercially available bovine PDI, as verified with the insulin 
turbidity assay. Enzymatic activity of the active site domain a showed a functional 
protein, bu t only at a 61% level of the full length protein. Kinetic parameters cannot 
be deduced from the insulin assay under these conditions, as it was just used to test 
the relative activity of the protein for functionality purposes. The characterization of 
the functional properties of both a and a ’ domains in work by Darby and Creighton 
in 1995, compared the activity in the reactivation of disulfide-scrambled ribonuclease 
A, disulfide folding of BPTI, and disulfide formation in model peptides. In these 
instances, the two active site domains were shown to be efficient in their ability to 
introduce disulfide bonds in unfolded proteins, but were less efficient than full length 
PDI in disulfide bond isomerization. The engineering of a recombinant full-length 
PDI was created to assist the study and characterization of the S-nitrosation activity 
of PDI. It was shown th a t PDI denitrosates S-nitrosoglutathione (GSNO), and that 
by auto-S-nitrosation of the active site through N2 O3 , PDI can act as a NO carrier 
(Sliskovic et al., 2005).
In studying PDI kinetics, it has been difficult to estimate initial rates of enzyme 
turnover. It has also been difficult to determine Michaelis-Menten parameters of PDI; 
enzyme rates increase as enzyme concentration is increased, and there are long lag 
phases before reactions are detectable. Many models of its mechanism have been 
proposed, bu t all lack experimental evidence to support them. In a study by Raturi 
and coworkers (2005), a more sensitive assay for PDI was developed, based on the
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PDI-dependent reduction of a synthetic fluorescent self-quenching probe di (o-amino 
benzoyl) glutathione disulfide (diabz-GSSG). The reduction of diabz-GSSG to (0- 
amino benzoyl)-glutathione (abz-GSH) by PDI results in an increase in fluorescence; 
it utilizes low concentrations of PDI, in an immediate reaction tha t can easily be 
monitered spectroscopically.
Coenzyme Q10 is the electron transporter in the mitochondrial respiratory chain, 
and has been shown to reduce apoptosis (Moon et al., 2005). Addition of coenzyme 
Q10 to the cell media was done as an attem pt to preserve transfected cells, and de­
lay senesence of the stably transfected cells. Unfortunately, no noticeable differences 
were seen in generating and maintaining stable cell lines between those cells receiving 
0.05 m g/m l of coenzyme Q10, and the cells receiving no extra treatm ent in its place. 
Although traditionally thought of as an enzyme localized specifically to the ER, more 
recent studies have shown tha t PDI is found throughout the cell. Cell surface PDI was 
identified on the surface of human blood platelets (Chen et al., 1995), mitochondrial 
PDI was found in ra t liver cells (Rigobello et al., 2000), and PDI has been located 
throughout the cytosol in astrocytes of glial cells (Safran et al., 1991). In this study, 
the localization of PDI in differentiated human neuroblastoma cells shows the disper­
sal of PDI throughout the cell, and into the dendridic arms, indicating tha t it is not 
only localized to the ER in SH-SY5Y cells. Implications for the potential purpose of 
this protein throughout the cytosol of these cells is discussed in section 3.4.
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Figure 2.1: cDNA amplification of full-length PDI. An image of the 1.5% agarose gel 
resolution of the PCR products. Lane 1 contains a DNA marker ranging from 10 Kb 
to 0.05 Kb. Lane 2 contains amplified PDI cDNA under an annealing temperature of 
55° C, and lane 3 contains amplified PDI cDNA under an annealing temperature of 
60°C.
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Figure 2.2: pET-28b:PDI fusion and restriction enzyme digest. An image of the 
1.5% agarose gel resolution of the plasmid extraction and restriction enzyme digest 
products. Lane 1 contains the DNA marker, lane 2 contains pET-28b plasmid, lane 3 
contains recombinant pET-28b:PDI, and lane 4 contains the restriction enzyme digest 
of pET-28b:PDI by restriction enzymes EcoRl and Hindlll.
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Figure 2.3: cDNA amplification of the active site domain of PDI. An image of the 
1.5% agarose gel resolution of the PCR products. Lane 1 contains amplified PDI 
cDNA under an annealing tem perature of 55° C, lane 2 contains amplified PDI cDNA 
under an annealing tem perature of 60°C, and lane 3 contains the DNA marker.
46
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
1
10 Kb




Figure 2.4: pET-28b:PDIa fusion and restriction enzyme digest. An image of the 1.5% 
agarose gel resolution of the restriction enzyme digest products. Lane 1 contains the 
DNA marker, lane two contains the restriction enzyme digest of pET-28b:PDIa by 
restriction enzymes EcoRl and HindllL
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Figure 2.5: Protein purification of recombinant PDI. An image of a 12% acrylamide 
gel containing recombinant PDI. Lane 1 contains the molecular weight (MW) markers 
ranging from 205 KDa to 6.5 KDa. Lane 2 contains protein eluted with 10 mM 
imidazole; lane 3 contains a second elution with 10 mM imidazole; lane 3 contains a 
third 10 mM imidazole wash; lane 4 contains protein eluted with 30 mM imidazole; 
lane 5 contains a second 30 mM wash, and lane 6  contains recombinant protein eluted 
with 250 mM imidazole.
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Figure 2.6: Protein purification of recombinant PDIa. An image of a 17% acrylamide 
gel containing recombinant PDIa. Lane 1 contains a MW marker ranging from 6 6  
KDa to 6.5 KDa. Lane 2 contains insoluble proteins in the pellet; lane 3 contains 
proteins eluted with a 10 mM imidazole wash; lane 4 contains a second 10 mM 
imidazole wash; lane 5 contains proteins eluted with a 30 mM imidazole wash, and 
lane 6  contains recombinant protein eluted with 250 mM imidazole.
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Figure 2.7: Ponceau-S stain of nitrocellulose prior to immunoblotting. Lane ] 
recombinant PDIa protein; lane 2 contains recombinant PDI protein; lane 2 
Sigma bovine PDI; lane 4 contains Bovine Serum Albumin (BSA), and lane I 
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Figure 2.8: Western blot of PDI and PDIa. An image of the colorimetric development 
by 3’,3’,5’,5!-Tctramethylbenzidine after immunoblotting. Lane 1 contains recombi­
nant PDIa protein; lane 2 contains recombinant full length PDI with 2 His6 tags; lane 
3 contains Sigma bovine PDI (positive control), and lane 4 contains BSA (negative 
control).
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Insulin Turbidity Assay
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Figure 2.9: Insulin turbidity assay of the recombinant proteins. Sigma bovine PDI 
and recombinant human PDI show similar enzymatic activity. Recombinant PDIa is 
active, but its activity is decreased in comparison to full-length PDI.
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0.05 Kb
Figure 2.10: cDNA amplification of full-length PDI. An image of the 1.5% agarose 
gel resolution of the PCR products. Lane 2 contains amplified PDI cDNA under an 
annealing tem perature of 55°C, and lane 1 contains the DNA marker.
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Figure 2.11: pEG FP-N l:PD I fusion and restriction enzyme digest. An image of the 
1.5% agarose gel resolution of the plasmid extraction and restriction enzyme digest 
products. Lane 1 contains the DNA marker; lane 2 contains plasmid pEG FP-N l; lane 
3 contains recombinant plasmid pEGFP-N l:PDI. In lanes 2 and 3 the linear, coiled, 
and supercoiled forms of the plasmid are observed. Lane 4 contains the restriction 
enzyme digest of plasmid pEG FP-N l:PD I by restriction enzymes EcoRl and KpnI.
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Figure 2.12: Immunoprecipitation of SH-SY5Y cells expressing the reporter protein. 
Lane 1 contains immunoprecipitation of the total cell lysate from transiently trans­
fected SH-SY5Y cells. Lane 2 contains the control immunoprecipitation of the total 
cell lysate from untransfected SH-SY5Y cells.
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Figure 2.13: Localization of PDI in differentiated SH-SY5Y cells. Photos above (A 
and B) and below (C and D) compare cell morphology and reporter protein localiza­
tion of selected cells. Photos A and C were taken under phase contrast microscopy, 
whereas photos B and D were taken under a fluorescent microscope, containing a blue 
UV filter. Arrows shown in B and D indicate the absence of PDLGFP in the nucleoli 
of the cells.
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Chapter 3 
Further Evidence of PD I as a 
Neuroprotective Protein
3.1 Objectives
In various stressful situations, PDI has been shown to be upregulated. For 
example, in primary cultured glial cells, the protein was upregulated under hy­
poxic/ischemic conditions (Tanaka et al, 2000). Overexpression was also demon­
strated in the brains of patients with CJD (Yoo et al, 2002). In the previous chapter 
the localization of the protein in SH-SY5Y cells was probed by creating a PDLGFP 
construct. To investigate further the properties of PDI as a neuroprotective protein, 
stable lines of SH-SY5Y cells were generated containing the PD LGFP construct. The 
promoter under which gene expression was controlled was the cytomegalovirus im­
mediate early (CMV IE) promoter, which is constitutively active. In introducing 
excess PDI to  SH-SY5Y cells, it was anticipated tha t a similar outcome demon­
strated by Tanaka, would occur under stressful conditions, and work to protect the 
cells. Furthermore, Bruening and coworkers (1998) identified th a t the activation of 
stress-activated mitogen activated protein kinases (MAPK) upregulated the expres­
sion of transgenes under control of the CMV IE promoter, and during ischemic stress 
members of the MAPK family are activated (Moriya et al, 2000). If the CMV IE 
promoter is activated through cell stress, then the PDLGFP construct would be over-
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expressed in the stable cell lines. This chapter sets out to examine further evidence 
of PDI as a neuroprotective protein under conditions of oxidative and ischemic stress 
in SH-SY5Y cells.
3.2 M ethods
3.2.1 Inducing Oxidative Stress by H 2 O2 Treatment
Oxidative stress was induced by adding H2 O2 to a final concentration of 100 /jM 
to the untransfected control cells, and to the pEG FP-N l and PD I:pEG FP-N l trans­
fected cells. After one hour, the media was changed, and the plates were incubated 
for three hours at 37°C, 5% CO2 . Apoptotic assays followed three hours after the 
treatm ent (Naderi et al., 2003).
3.2.2 Inducing H ypoxia
Cell media was replaced with a controlled salt solution (110 mM NaCl, 5.4 mM 
KC1, 0.8 mM MgCb, 1.8 mM CaCl2 , 15 mM NaHCOa, 15 mM glucose, 15 mM hepes, 
and 50 mM glycine, pH 7.4). Cells were put in a Gas Pack (anaerobic vessel) with 
a catalyst th a t consumed the remaining oxygen in the tank. An anaerobic indicator 
was used to moniter the decrease in oxygen. The cells were left in the tank for 6  
hours, and media was changed (Munir et al., 1995). The cells were monitered by 
counting the number of live cells per 100 in three different areas in 35 mm2 plates 
over a 48 hour time period. Three trials were done and three sets of measurements 
were taken for each. Averages were taken for each trial, and percentage error was 
calculated between all trials.
3.2.3 Cellular Staining and M icroscopy
SH-SY5Y nuclei were stained by adding Hoechst 33342 dye (Molecular Probes) 
to a 10 fiM  final concentration to cell media and incubating for 10 minutes. Mitochon­
dria were stained by adding Mitotracker dye (Molecular Probes) to a 100 nM final
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concentration to the cell media. Phosphatidylserine in the cell membrane was stained 
by adding 1.5 /il of Annexin V 594 (Molecular Probes) per 3 ml of annexin-binding 
buffer (10 mM HEPES, 140 mM NaCl, 2.5 mM CaCl2 , pH 7.4), and incubating for 
15 minutes. Following incubation of the Hoechst and Mitotracker dyes, the media 
was removed and replaced with IX Phosphate Buffered Saline (PBS) pH 7.4. The 
cells were examined under a fluorescent and phase contrast microscope. Photos were 
taken a t 100, 400, and 600 x magnification and processed using Adobe Photoshop 6.0 
software.
3.2.4 R educed G lutathione (GSH) M easurem ents
Control and transfected SH-SY5Y cells were treated with 100 /iM H2 O2 . Three 
hours following treatm ent, the total cell lysate was prepared, and 50 /A of the lysate 
was added to 100 fil of reaction buffer (1 mM NADPH, 100 mM Na2H P 0 4 , 100 units 
GSH reductase, and 1 mM DTNB). This mixture was incubated for five minutes 
at room tem perature (Baker et al., 1990). Absorbance was measured at 412 nm in 
a 96-well microtiter plate using Bio-tek ELX 808ru U ltra Microplate reader. The 
amount of reduced glutathione was expressed per microgram of measured protein. 
Three sets of experiments were done and three sets of measurements were taken for 
each experiment. Averages were calculated from the results in each trial, and the 
percentage error between each set of experiments was calculated.
3.2.5 M easurem ent of Total R eactive O xygen Species (ROS)
Detection of ROS production was monitered using the membrane permeable dye 
2’,7’-dichlorofluorescein diacetate (DCFDA) (Siraki et al., 2002). Measurement of 
total ROS production was measured after 3 hours of treatm ent with 100 fiM  H20 2 
in control and transfected SH-SY5Y cells. DCFDA was added to the cell media to 
a final concentration of 10 fiM, and incubated for 10 minutes a t 37°C. Cell lysate 
was collected, and the pellet was resuspended in 1 X PBS, pH 7.4. Fluorescence 
was measured using a Spectra Max Gemini XS multi-well plate fluorescence reader at
59
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
an excitation wavelenth of 500 nm, and an emission wavelength of 520 nm. Protein 
estimation was measured using the Bradford reagent at an absorbance of 595 nm. 
Results were expressed as a measurement of fluorescence units per microgram of 
protein. Three sets of experiments were done and three sets of measurements were 
taken for each experiment. Averages were calculated from the results in each trial, 
and the percentage error between each set of experiments were calculated.
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3.3 Results
3.3.1 O xidative and H ypoxia M easurem ents in Undifferenti­
ated SH -SY 5Y  Cells
Control cells and stable lines of undifferentiated SH-SY5Y cells expressing both 
GFP and PDLGFP were subjected to treatm ent with 100 fiM. H2 O2 , for one hour. 
Following three hours, the cells were stained with Hoechst (to examine nuclear mor­
phology) and Mitotracker (to examine mitochondrial membrane potential) dyes to 
access the morphological characteristics of apoptosis (figure 3.1). Cells were exam­
ined under a fluorescent microscope at a magnification of 400 x. For both lines of 
control cells, the characteristic of nuclear condensation (blue cells) was shown in fig­
ure 3. IB and 3. IE  by the rounding up, and clumping of cells. Figure 3.1H contains 
the PDLGFP cells, showing a reduction in nuclear condensation and cell clumping. 
The arrow indicates the single apoptotic nucleus found in th a t frame. A loss of mi­
tochondrial membrane potential of both lines of control cells was observed through 
the diffusion of the red stain in figure 3.1C and 3.IF. In figure 3.11 containing the 
PDLGFP cell line, the presence of more pronounced, stained mitochondria indicates 
the maintenance of membrane potential. Maintenance of mitochondrial membrane 
potential was observed in greater than 75% of the observed PDLGFP containing cells.
Following cellular staining, the total cell lysate of each cell line was collected, 
and DCFDA, a fluorescent probe which measures the amount of ROS, was added 
to the lysate. A measurement of the total fluorescence expressed per microgram of 
protein was quantified (figure 3.2). These experiments were repeated three times, and 
measurements were taken three times for each trial. Green columns represent ROS 
measurements in untreated cells, and violet columns represent ROS measurements 
cells exposed to oxidative stress. In the PDLGFP cells, there is a reduced production 
of ROS as compared to the control lines. On average ROS levels increase by 16 
fluorescence units per microgram protein in the control cells, whereas they increased 
only by 5 fluorescence units per microgram protein in the PDLGFP cells. In parallel,
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the number of micromoles of reduced glutathione produced per microgram of protein 
was measured in treated and untreated cells. Detection with DTNB determined 
the number of reduced thiols for undifferentiated cells treated with H2 O2 . Three 
separate experiments were done measuring the number of reduced thiols, and three 
measurements were taken for each trial. Green panels in figure 3.3 represent the 
glutathione measurements in untreated cells, and violet panels represent glutathione 
measurements in cells exposed to oxidative stress. Figure 3.3 demonstrates a large 
reduction in the amount of GSH, an average of 2.5 pmol//rg of protein, in both control 
lines after exposure to oxidative stress. There is a smaller reduction in GSH levels of 
0.4 pmol//xg of protein in cells expressing PDLGFP.
Undifferentiated transiently transfected GFP and PDLGFP cells were treated with 
100 jjM  H2 O2 , for one hour. Following three hours, the cells were stained with An- 
nexin V dye to observe membrane flipping of phosphatidylserine, which is indicative 
of the early stages of apoptosis. Once the dye is bound to phosphatidylserine on 
the outer leaflet, a visible orange colour outling the membrane is present. Cells were 
examined under a fluorescent microscope at a magnification of 400 x. In figure 3.4A, 
cells are untreated and there are no GFP expressing cells, and no cells th a t take up 
the annexin V dye. In figure 3.4D and 3.4G, untreated cells show the presence of 
GFP, and PDLGFP cells, respectively. In both D and G panels, no annexin binding 
is present as expected in untreated cells. In the transiently transfected GFP cells, 
figure 3.4E shows only the annexin V binding dye, and figure 3.4F shows the identical 
field of view with G FP expressing cells. It is observed th a t the G FP only cells take 
up the annexin V binding dye indicating phosphatidylserine membrane flipping. In 
the transiently transfected PDLGFP cells, figure 3.4H show cells th a t take up the 
annexin V binding dye. In figure 3.41, the identical field of view shows the pres­
ence of PDLGFP expressing cells tha t did not take up the annexin V stain. Hence, 
SH-SY5Y cells containing PDLGFP seem to evade early apoptotic cellular reponses 
during hypoxic stress.
Undifferentiated control and stably transfected lines of SH-SY5Y were subjected to 
hypoxic stress for six hours in a hypoxia chamber. All three cell lines were counted in
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three different fields of view, at 0, 4, 6 , 12, 24, and 48 hours following treatm ent. After 
48 hours, all control lines were non-viable, whereas the PDLGFP cell line still had 
approximately 20% of viable cells (figure 3.5). Therefore, the presence of PDLGFP 
in SH-SY5Y cells delays apoptosis caused by hypoxic stress.
3.3.2 Inducing Oxidative Stress in Differentiated SH -SY5Y  
Cells
Control SH-SY5Y cells, and a stable line of PDLGFP cells were differentiated 
over 14 days. Figures 3.6A and 3.6B show phase contrast pictures of the morphology 
of differentiated control cells before treatm ent with hydrogen peroxide. The elonga­
tion of the cell body, and the neurite growth can be seen between the cells. Figure 
3.7 shows the side by side comparison of phase contrast and fluorescence micrscopy 
pictures of differentiated PDLGFP cells before treatm ent with hydrogen peroxide. 
Cell body elongation, and neurite growth can be seen in the PDLGFP cells, with the 
presence of the recombinant PDLGFP throughout.
Following differentiation, cells were treated with 100 m uM  H2O2 , for one hour. 
After three hours cells were stained with Hoechst and Mitotracker dyes to examine the 
cells for the apoptotic features of nuclear condensation and mitochondrial membrane 
potential. Cells were examined under phase contrast and fluorescent microscopy at 
400 x magnification. Figures 3.8 and 3.9 are two examples of the comparison of treated 
control and PDLGFP cells. All of the nuclei of the control cells were condensed and 
rounded, indicative of nuclear condensation during cell death in figures 3.8E and 3.9E, 
whereas most of the nuclei in PDLGFP cells maintained normal morphology as in­
dicated by the absence of cell rounding, and clumping (figure 3.8F and 3.9F). The 
blurry red colour seen in figures 3.8C and 3.9C of the control cells indicate a loss of 
mitochondrial membrane potential. The mitochondrial membrane potential of most 
PDLGFP cells remained intact as exhibited by the defined red colour in figures 3.8D 
and 3.9D. Figure 3.10 shows more phase contrast and fluorescent microscopy pictures 
of additional PDLGFP cells after treatment; figures 3.10B and 3.10 D show tha t
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nuclear morphology is intact, figures 3.10B and 3.10D indicate tha t mitochondrial 
membrane potential is preserved. These photographs further support th a t the pres­
ence of PDLGFP in differentiated SH-SY5Y cells protects against apoptosis induced 
by oxidative stress.
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3.4 D iscussion
Many studies of apoptosis often work towards application for neurodegenerative 
diseases and stroke. To gather further evidence for PDI as a neuroprotective protein, 
SH-SY5Y neuroblastoma cells were chosen as an appropriate model. In working with 
these cells, difficulties arose in tha t their number of divisions was very limited and 
finite. It was im portant to generate lines of stable cells, and perform experiments 
before cells reached senescence, which usually occurred between divisions 1 0  and 1 1 . 
Also, because of this obstacle for every set of experiments undertaken, new stable 
cell lines had to be generated, and no stocks of cells could be made. This created a 
quandary in th a t the characteristics of each new cell line generated may have varied. 
Characteristics aside, the assumption was made th a t PDI function within the cell 
should remain the same.
3.4.1 Stable SH -SY 5Y  Cells Expressing PDIrG FP are Pro­
tective Against O xidative Stress
Reactive oxygen species in the cell include superoxide, peroxynitrite, and the hy­
droxy radical. Oxidative stress has been shown to induce apoptosis in systems such 
as muscle and neuronal cells (Kroemer et al., 1997). Oxidative stress was induced 
artificially in the cells with hydrogen peroxide treatm ent. Although not understood, 
cell death by ROS has been hypothesized to lead to mitochondrial dysfunction with 
the release of cytochrome C and apoptosis initiating factor, which then activates a 
caspase pathway (Strasser et al., 2000). Alternatively, ROS could cause DNA dam­
age, and lead to a p53/Bax pathway inducing apoptosis (Li et al., 1999). A recent 
paper by Chun and coworkers in 2001, proposed th a t ROS induced JNK1/2-MAPK, 
followed by cJun phosphorylation, and the expression of cell death genes. If ROS 
induces cell stress through the JNK1/2-MAPK pathway, then expression of the CMV 
IE promoter may have been upregulated, and in doing so, upregulated the expression 
of the recombinant PDLGFP. This appears to be evident in the results, in tha t in­
ducing stress with ROS preserved nuclear morphology and mitochondrial membrane
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potential in those cells containing PDLGFP, whereas cell death was marked in un­
transfected cells, and transfected cells expressing G FP only. Measurement of ROS 
produced by the cells after oxidative stress was measured, and showed an average 
increase of 15 fluorescence units per microgram of protein in both lines of control 
cells, whereas the average increase in cells expressing the PDLGFP protein was only 
6  fluorescence units per microgram of protein, almost a 3-fold decrease. Clearly, intro­
ducing an excess of PDI into SH-SY5Y cells shows to delay the apoptotic mechanism 
in evading cell death. Phosphatidylserine flipping, an early apoptotic event was de­
tected using Annexin V dye on transiently transfected cells. Annexin V only binds to 
phosphatidylserine exposed on the cell surface when it flips from the inner to outer 
leaflet of the cytoplasmic membrane.
3.4.2 Stable SH -SY 5Y  Cells Expressing PDIrGFP M aintain  
the R edox Balance
Redox balance throughout the cell is maintained by the relative concentrations 
of GSH:GSSG. The cytoplasm of the cell is generally a very reducing environment, 
with concentrations of GSH:GSSG residing around 30:1 - 100:1 (Raina and Missi- 
akas, 1997). Under oxidative stress, the environment in the cytoplasm becomes more 
oxidative and the concentration of GSH decreases, as it is oxidized to GSSG. GSH 
levels were measured using 5,5’-dithio-6is- (2-nitrobenzoic acid), or DTNB which re­
acts with free sulfydryl groups resulting in the formation of 2-nitro-5-thiobenzoic acid 
(TNB) and a mixed disulfide (Riener et al., 2002). The average decrease in GSH levels 
in both lines of control cells under oxidative stress was 2.5 picomoles per microgram 
of protein, whereas the average decrease in cells expressing PDLGFP was only 0.4 
picomoles per microgram of protein. This demonstrates th a t PDI works to maintain 
the reducing environment within the cells under stress.
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3.4.3 Stable SH -SY 5Y  Cells Expressing P D L G F P  D elay A pop­
tosis
Ischem ia, a  con d ition  caused by lack of oxygen  to  cells can  resu lt in m assive  
cell death, especially in brain stroke. It has been demonstrated th a t PDI expression 
is elevated only in the cerebral cortex of rats with brain ischemia, but not in the 
hippocampus, cerebellum, or other areas (Tanaka et al, 2000). The number of viable 
cells remaining in control lines and PDLGFP lines were assessed over a 48 hour 
period after ischemic stress. By 48 hours all of the control cells had died, whereas 
the PDLGFP cell line still had an average of 20% of viable cells remaining. This 
observation again exhibits the neuroprotective effect PDI has in SH-SY5Y cells.
3.4.4 D ifferentiated Stable SH -SY5Y Cells Expressing PD L G FP  
P rotect Cells from ROS
Control and stable cell lines were differentiated not only to localize PDLGFP 
within SH-SY5Y cells, but also to examine the presence of nuclear morphology and 
mitochondrial membrane potential associated with apoptosis following hydrogen per­
oxide treatm ent. Over the course of 14 days of treatm ent and cell differentiation, 
many cells died in all lines; the stable GFP cell lines did not remain viable, and 
most had died off by the tenth day. A possible reason for the complication could be 
the presence of G418 in the serum deprived media containing only BDNF. G418 is a 
selective antibiotic which can only be metabolized by the enzyme neomycin phospho­
transferase, whose gene is found in the pEG FP-N l plasmid. The presence of G418 in 
the media keeps the plasmid inside the SH-SY5Y cells. Any cells th a t do not contain 
the plasmid, are killed by the toxic antibiotic, as they do not contain the gene to 
metabolize it. The high copy number of the plasmid also allowed for a high number 
of plasmid replication. Excess PDI in the PDLGFP strain may have contributed to 
the maintenance of the cell line during differentiation. Pictures comparing the control 
and PDLGFP line after differentiation show a decreased level of neurite growth in 
the PDLGFP line, and a decreased number of neurite contacts made, as compared to
67
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
the control cells. Again, this may be due to the presence of G418 within the media, 
which may somehow hinder the growth and formation of differentiated cells. Upon 
treating the cells with hydrogen peroxide, these studies demonstrate definitively tha t 
the PDLGFP cell line does protect the cells from oxidative stress to an extent. Cell 
death appears to be slowed down in the PDLGFP cells as compared to the control 
cells, although initial characteristics of apoptosis begin to  appear with the beading 
of neurites as illustrated in figures 3.8F and 3.9F.
In summary, additional evidence was gathered to support th a t PDI works as a 
neuroprotective protein in response to oxidative and ischemic stress. PDLGFP cells 
maintained nuclear morphology, and mitochondrial membrane potential during ox­
idative stress. These cells showed a much lesser increase in the level of ROS produced 
as compared to the control cells. Reduced glutathione levels in the PDLGFP cells 
were closer to untreated levels after oxidative stress than the control cell lines. These 
effects may be contributed to the upregulation of another protein - ubiquilin, which 
has been shown to associated with PDI during stress induced cell death (Ko et al., 
2002). A marked reduction in the apoptosis of PDLGFP cells may also be attributed 
to its anti-chaperone activity within the cell (Quan et al, 1995, Goldberg et al., 1991, 
Walker and Gilbert, 1997). PDI can act as an anti-chaperone to  aggregate unfolded 
proteins within the endoplasmic reticulum to help protect them  from protein degra- 
tion.
Previous studies have also proposed tha t ROS may be involved with the activation 
of NF-kB (Li et a l, 1999). A recent study proposed th a t PDI suppresses NF-AB activ­
ity (Higuchi et al, 2004). This may also in some way contribute to cell death protec­
tion. This localization of SH-SY5Y cells using recombinant PDLGFP demonstrated 
tha t this protein was found throughout SH-SY5Y cells. Lahav and coworkers (2000) 
identified PDI at the cell surface of blood platelets mediating integrin-dependent ad­
hesion, although it was not stated how many disulfide bonds are oxidized or reduced 
in the integrins. During apoptosis, cells begin to detach from each other and from 
their matrix. The ability of PDI to delay cell death may also be dependent on its 
ability to promote disulfide exchange in integrin adhesion.
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More research needs to be conducted on the ability of PDI to protect cells from 
death. Its protein-protein interactions, downstream signalling, and mechanism by 
which it functions still needs to be elucidated. Once more is understood about PDI, 
drugs th a t could further upregulate its expression may be useful in treating stroke 
victims and other diseases marked by massive cell death.
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Figure 3.1: Morphology of control and stable SH-SY5Y cells following oxidative stress. 
Undifferentiated SH-SY5Y cells were treated with 100 /jM  hydrogen peroxide. Fol­
lowing three hours, cells were examined for the presence of morphological features of 
apoptosis including cell lifting, nuclear condensation, and mitochondrial membrane 
potential. Frames A, B, and C show the phase contrast, Hoechst stain, and Mi­
totracker stain respectively, of the untransfected control cells. Frames D, E, and F 
show the phase contrast, Hoechst stain, and Mitotracker stain of the GFP transfected 
control cells. Frames G, H, and I show the phase contrast, Hoechst stain, and Mi­
totracker stain of the PDLGFP transfected cells. The arrow in Frame H points to 
a condensed nucleus found within the PDLGFP field of view. All photographs were 
taken at 400 x magnification.
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Figure 3.2: Production of reactive oxygen species in control and stable SH-SY5Y 
cells. Undifferentiated SH-SY5Y cells were treated with 100 fiM  hydrogen peroxide. 
After three hours, cell lysate was collected and 2’,7’-dihydrofluorescein (DCFDA) flu­
orescent dye was added to the lysate. Measurements of the reactive oxygen species in 
both treated and untreated cells were taken, and expressed as the number of fluoresc- 
net units per microgram of protein. The first two bars represent the untransfected 
control cells, the second set represent the stable cells expressing only GFP, and the 
third set represent the stable cells expressing PDLGFP. Error bars are based on the 
standard error between sets of experiments.
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Figure 3.3: Measurement of GSH levels after oxidative stress in control and stable 
SH-SY5Y cells. Undifferentiated SH-SY5Y cells were treated with 100 fiM  hydrogen 
peroxide. Following three hours, cell lysate was collected and incubated with the 
reaction buffer as described in the methods section. GSH levels in both treated and 
untreated cells were measured and expressed per microgram of protein. The first two 
bars represent the untransfected control cells, the second set represents the stable 
cells expressing only GFP, and the third set represents the stable cells expressing 
PDhGFP. Error bars are based on the standard error between sets of experiments.
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Figure 3.4: Membrane flipping of control and transiently transfected SH-SY5Y cells 
after oxidative stress. Undifferentiated SH-SY5Y cells were treated with 100 fjM 
hydrogen peroxide. Following three hours, cells were examined for the phosphatidyl 
serine flipping using Annexin V dye. Frame A shows the untreated control cells, frame 
B and C show the treated control cells (the same frame is used to show the absence 
of G FP cells within the control line). Frame D shows untreated G FP cells, frame 
E displays treated G FP cells, and frame F displays the same field of view as E, but 
showing both GFP and annexin V binding. Frame G displays untreated PDLGFP, 
frame H displays treated PDLGFP cells, and frame I displays the same field of view 
as H, but showing both PDLGFP cells in the presence of annexin V binding. All 
photographs were taken at 400 x magnification, under fluorescent microscopy.
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Figure 3.5: Assessment of cell viability following ischemic stress. Undifferentiated 
control and stable SH-SY5Y lines were subjected to ischemia for 6  hours. Cells were 
examined using phase contrast microscopy, and three different areas were counted for 
the number of viable cells following stress induction at time periods of 0, 4, 6 , 12, 24, 
and 48 hours. Results were expressed as a percentage of viable cells remaining. Error 
bars are based on the standard error between sets of experiments.
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Figure 3.6: Differentiated SH-SY5Y cells before oxidative stress. Cells were differen­
tiated for 14 days as described in the methods section. Phase contrast photographs 
were taken of the cells prior to inducing oxidative stress, to examine for morpholog­
ical features of differentiated cells which include, cell body elongation, and neurite 
lengthening and contact. Frames A and B show two different fields of view of the 
differentiated control cells. All pictures were taken at 400 x magnification under a 
phase contrast microscope.
75
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
Figure 3.7: Differentiated PDLGFP SH-SY5Y cells before oxidative stress. Cells 
were differentiated for 14 days as described in the methods section. Photographs 
of the cells were taken prior to inducing oxidative stress, to examine morphological 
features of differentiated cells. Frames A and C show two different fields of view of 
the differentiated PDLGFP cells under phase contrast microscopy. Frames B and 
D show the same frames as A and C, under fluorescent microscopy. Cells in frames 
B and D were examined for the presence of the recombinant PDLGFP protein. All 
pictures were taken at 400 x magnification.
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Figure 3.8: Morphology of control and stable differentiated SH-SY5Y cells after oxida­
tive stress. Differentiated SH-SY5Y cells were treated with 100 /iM hydrogen perox­
ide. Following three hours, cells were examined for the presence of the morphological 
features of apoptosis including cell lifting, nuclear condensation, and mitochondrial 
membrane potential. Frames A, C, and E show the phase contrast, Hoechst stain, 
and Mitotracker stain respectively, of the control cells. Frames B, D, and F show 
the phase contrast, Hoechst stain, and Mitotracker stain of the PDIrGFP cells. All 
photographs were taken at 400 x magnification. Frames A and B were taken under 
phase contrast microscopy, and frames C, D, E, and F were taken under fluorescent 
microscopy.
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Figure 3.9: Morphology of control and stable differentiated SH-SY5Y cells after ox­
idative stress. Following three hours, cells were examined for the presence of the 
morphological features of apoptosis including cell lifting, nuclear condensation, and 
mitochondrial membrane potential. Frames A, C, and E show the phase contrast, 
Hoechst stain, and Mitotracker stain respectively, of the control cells. Frames B, D, 
and F show the phase contrast, Hoechst stain, and Mitotracker stain of the PDLGFP 
cells. All photographs were taken at 400 x magnification. Frames A and B were 
taken under phase contrast microscopy, and frames C, D, E, and F were taken under 
fluorescent microscopy.
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Figure 3.10: Morphology of differentiated PDLGFP cells following oxidative stress. 
Differentiated PDLGFP cells were examined for the presence of the morphological 
features of apoptosis. Frame A shows cells under phase contrast microscopy, frame B 
shows cells stained with Mitotracker, frame C shows PDLGFP protein and Hoechst 
stained nuclei, and frame D shows cells stained with both Mitotracker and Hoechst. 
All photographs were taken at 400 x magnification. Frame A was taken under phase 
contrast microscopy, and frames B, C, and D were taken under fluorescent microscopy.
79
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
Chapter 4
Directions for Future Study
In further studies of PDI as a neuroprotective protein, it is im portant to deter­
mine how it interacts with other molecules within the cell. During ischemic stress, 
inducible NO synthase is upregulated which generates excess amounts of nitric oxide 
(Moriya et al., 2000). Moriya and coworkers also demonstrated th a t excess NO causes 
apoptosis through the initial loss in mitochondrial membrane potential and final 
downstream caspase signalling resulting in DNA degradation. It has been suggested 
tha t PDI is involved with the transport of intracellular NO equivalents (Sliskovic et al., 
2005). Future work could include the study of the addition of PDLGFP to SH-SY5Y 
cells, and on the determination of the intracellular NO levels when cells are exposed 
to ischemic stress. PDI denitrosation activity can easily be monitored with the highly 
fluorescent and sensitive probe, A-dansyl-S-nitrosohomocysteine (DAN), tha t reacts 
with NOs , to form napthotriazole (NAT), which emits a fluorescent signal at 406 nm 
(Raturi and Mutus, 2004). By using this probe on the cell lysates of PDLGFP cells 
exposed to ischemic stress, PDI denitrosation activity can be monitered.
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A ppendix  A
T he P D I sequence used throughout th is th esis w as ob tained  from th e  
P D I cD N A  cloned into  th e pET-1 la  vector, and sequenced  at th e  W ayne 
State sequencing facility. C onversion o f th e  D N A  to  protein  sequence was 
done using th e  E xP A S y proteom ic too l from www.expasy.org.
1 10 20 
D A P E E E D H V L V L R K S N F A E A L A A H K Y  
JO 40 50
L LV E F Y A P f  C f l H C  K A L A  P E Y  A K A A G K
60 70
L K A E O S E I R L A K V D A T E E . S D L A Q Q Y G V  
80 90 100
R G Y P T I K F F R N  O D I A S P K E Y T A O R E A D  
110 120 130
D I V N W L K K R T G P A A T T L P D G A A A E S L  
140 150 160
V E S S E V A V I G F F K D V E S D S A K Q F L Q A A  
170 180
E A I D D I ' P F G I T S X S D V F S K Y Q L D K D G  V 
190 200 210
V L F K K F D E X R N N F E G E V T K G E P A G L Y  
220 230 240
0  T Q P A  A P C H R V P E Q T A P K I F  0 G X I K T H  
250 260
I L L F L P F L P K S V S D Y D G K L S N F K T A A E S  
270 280 290
F K G K I L F I F I D S D I T D N Q R I L E F F G L K K  
300 310 320
E E C P A Y E L I T L E E E M 1 K Y K P E S E E L T A  
330 340 350
E R I T E F C H R F L E G K I R P H L M S Q E L P E C
360 370
W D K . Q P V K V L V G K N F E D V A F D E K K N V F  
380 390 400
V E F Y A P W  C G H C K Q L A P I W D K . L G E T Y K .
410 420
D H E N I V I A K M D S T A . N E V E  A V K V H S F P T  
430 440 450
L K F F P A S A D R T V I D Y N ' G E R T L D G F K K F  
460 470 480
L E S G G Q D G A G D D D D L E D L E E A E E P D  M 
490
E E I) D D 0  K A V K D E L
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A ppendix  B
pE T -28b vector from N ovagen www.novagen.com
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A ppendix  C
Below is the FORTRAN 90 code to generate primers given an insert and vector 
saved in FASTA format under insert.txt and vector.txt respectively. Once the pro­
gram is opened, answer the list of questions prompted by the program. Restriction 
enzymes are to be entered by nucleotide sequence instead of names. Once all of the 
information has been inputted, the program will generate forward and reverse primers 
in the 5’ to 3’ direction based on the information given.
PROGRAM primer
INTEGER amax, vmax, cmax, emax
PARAMETER (amax=2500, vmax=500, cmax=100, emax=10)
CHARACTER rdarray*(amax),rdrev*(amax)
CHARACTER insertfor*(cmax), insertmed*(cmax), insertrev*(cmax), & 












write(*,*)’* ------------------------------------------  * ’
write(*,*)’* I Primer Generator I*’
writ;e(*,*)’* | By: R.A. Nistor and D. Seslija I*’
write(*,*)’* | To be used under the GNU Licence. j*’
write(*,*)’* ------------------------------------------  * ’
write(*,*)’* I Comments? Questions? ... :( |*’




open (unit=80, file=’insert.txt’, status=)0LD> ) 
read (unit=80,fmt=’(A\a)’)rdarray
98




call COUNTNUCS(rdarray,amax,nins,nc,ng,n t ,n a ,ns) 
write(*,fmt=’(A10,15,A18)’) ’Insert is’, nins,’nucleotides long, 
write(*,fmt=’(A9,I4,A3,I4,A3,I4,A3,I4,A19,I4,A8)’)&
’Contains’,nc,’C,’,ng,’G, ’,nt,’T , ’,& 












call COUNTNUCS(rdarray,amax,nvec,nc ,n g ,nt ,n a ,ns) 
write(*,fmt=’(A10,14,A18)’) ’Vector is’, nvec,’ nucleotides long 
write(*,fmt=’(A9,I3,A3,I3,A3,I3,A3,I3,A19,I3,A8)’)&
’Contains’,nc,’C , ’,ng,’G,’,nt,’T, ’,& 













write(*,*)’Please enter a Temperature range (in Cel.)’ 
write(*,fmt=’(\A10)’) ’ Initial: ’ 
read.(*, *)tl
write(*,fmt=’(\A10)’) ’ Final: ’
read.(*,*)t2
write(*,fmt=’(A21,F6.1 ,A3,F6.1,A10)’)’Temperature range = ’,& 
tl,’to ’,t2,’ deg. Cel.’ 
write(*,*) ’----------------------------------------------- ’
nc=0; ng=0; nt=0; na=0; ns=0; 
found=.false, 
do 20 i=l,cmax
if ( insertfor(i:i).eq.’C ’ ) nc=nc+l
if ( insertfor(i:i).eq.’G ’ ) ng=ng+l
if ( insertfor(i:i).eq.’T ’ ) nt=nt+l
if ( insertfor(i:i).eq.’A ’ ) na=na+l
t=TEMP(nc,n g ,n t ,na) 
temperaturefor(i)=t 
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write(*,fmt=’(A31,12,A4,F6.1,A11)’)’For insert, found at position ’ , k  
i , \  T = ’,t
goto 200 
end if
if ( .NOT.found .AND. t.gt.t2 ) then
write(*,*)’ERROR: Temperature range is possibly too small for insert’ 
write(*,fmt=’(A24,I3,A7,F6.1,A2,F6.1)’) ’For nucleotide position’, & 




if ( i.eq.cmax) then
write(*,*)’ERROR: Temperature range too high’






nc=0; ng=0; nt=0; na=0; ns=0; 
found=.false. 
do 21 i=l,cmax
if ( insertrev(i:i).eq.’C ’ ) nc=nc+l
if ( insertrev(i:i).eq.’G ’ ) ng=ng+l
if ( insertrev(i:i).eq.’T ’ ) nt=nt+l
if ( insertrev(i:i).eq.’A ’ ) na=na+l
t=TEMP(nc,n g ,n t ,na) 
temperaturerev(i)=t 




’For insert compliment, found at position ’,i,’, T = ’,t 
goto 300 
endif
if ( .NOT.found .AND. t.gt.t2 ) then
write(*,*)’ERROR: Temperature range is possibly too small for insert comp.’ 
write(*,fmt=’(A24,I3,A7,F6.1,A2,F6.1)’) ’For nucleotide position’,& 




if ( i.eq.cmax) then
write(*,*)’ERROR: Temperature range too high’
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write(*,fmt=’(\A41)’) ’After what position is this enzyme cut: ’ 
read(*,*)cutl
write(*,fmt=’(\A42)’) ’Please enter the 2nd restriction enzyme: ’ 
read(*,fmt=’(A\a)’)enzb
call CAPITALIZE(enzb,emax) 
c al1 CHECKARRAY(enzb,emax) 
nenzb=FINDSIZE(enzb,emax)
write(*,fmt=’(\A41)’) ’After what position is this enzyme cut: ’ 
read(*,*)cut2
if ( cutl.gt.nenza .OR. cut2.gt.nenzb) then




write(*,fmt=’(\A25)’) ’1st restriction enzyme: ’ 
do 22 i=l,nenza
write(*,fmt=’(\A1)’)enza(i:i)
if ( i.eq.cutl ) write(*,fmt=’(\A1) ’) ’ | ’
22 continue 
write(*,*)
write(*,fmt=’(\A25)’)’2nd restriction enzyme: ’ 
do 23 i=l,nenzb
write(*,fmt=’(\A1)’)enzb(i:i)




write(*,fmt=’(\A51)’) ’Are you satisfied with these selections (y or n)? ’ 
read.(*,*) choice 
if ( choice.eq.’y ’ ) then 
goto 500 
else if ( choice.eq.’n ’ ) then 
goto 300










if ( posl.eq.O ) then
write(*,*)’ERROR: 1st restriction enzyme not found in vector’ 
goto 300 
endif
if ( pos2.eq.O ) then 
write(*,*)’ERROR: 2nd restriction enzyme not found in vector’ 
goto 300 
endif
if ( posl.gt.pos2 ) then
101
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write(*,*)’ERROR: 2nd restriction enzyme found before 1st.’
600 continue
write(*,fmt=’(\A29)’) ’Enter new enzymes (y or n)? ’ 
read(*,*)choice 
if ( choice.eq.’y ’ ) then 
goto 300 
else if ( choice.eq.’n’ ) then 
Stop




write(*,fmt=’(A10,A20,I3,A10)’)enza(1:nenza),’ occurs at position’,posl,&
’in vector’
write(*,fmt=’(A10,A20,13,A10)’)enzb(1:nenzb),’ occurs at position’,pos2,&
’in vector’
write(*,fmt=’(A10,A20,I3,A21)’)enzb(l:nenzb),’ occurs at position’,pos3,&
’in vector compliment’ 
write(* ,*) ’----------------------------------------------- ’
if ( pos3.eq.O ) then
write(*,*)’ERROR: restriction enzyme not found in the compliment.’ 






























if ( enza(i:i).ne.’ ’ ) then 
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outl(j: j) = ’A ’ 














if ( enzb(i:i).ne.’ ’ ) then 











write(*,*)’Primers in the 5p -> 3p direction are:’ 
write(*,*)
write(*,fmt=’(A18,F6.1,\A3)’) ’Forward Primer (T=’,temperaturefor(ntempfor),’) 
do 40 i=l,noutl
write(*,fmt=’(\A1)’)outl(i:i)
if ( i.eq.ocutl ) write(*,fmt=’(\A1) ’) ’ I ’
if ( i-(i/3)*3.eq.O ) write(*,fmt=’(\A1)’) ’ ’
40 continue 
write(*,*)
write(*,fmt=’(A18,F6.1,\A3)’) ’Reverse Primer (T=’,temperaturerev(ntemprev),’) 
do 41 i=l,nout2
write(*,fmt=’(\A1)’)out2(i:i)
if ( i.eq.ocut2 ) write(*,fmt=’(\A1)’) ’I’
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s=0
do 10 i=l,pos
if ( vector(i:i).eq.’ ’ ) s=i 
10 continue 
rf=pos-s





do 10 i=l,size 
match=0
100 continue
if ( vector(i+k:i+k).eq.string(j:j) ) then 
match=match+l 
if ( match.eq.dim ) then 
pos=i 
endif













subroutine COUNTNUCS(array,logicalsize,size,n c ,n g ,n t ,n a ,ns)
INTEGER i ,logicalsize,size,nc,ng ,n t ,n a ,ns 
CHARACTER array*(logicalsize)
nc=0; ng=0; nt=0; na=0; ns=0; 
do 10 i=l,size
if (array(i:i).eq.’C ’)nc=nc+1 
if (array(i:i).eq.’G ’)ng=ng+l 
if (array(i:i).eq.’T ’)nt=nt+l 
if (array(i:i).eq.’A ’)na=na+l 
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do 10 i=l,amax 
rdarray(i:i) = ’ ’
10 continue
end subroutine BLANK




do 10 i=l,size 
if ( for(i:i).eq 
if ( for(i:i).eq 
if ( for(i:i).eq 
if ( for(i:i).eq 
if ( f or (i:i).eq 
10 continue
’C ’ ) rev(i:i) = *G * 
’G ’ ) rev(i:i)=’C ’ 
’T ’ ) rev(i:i)=’A ’ 
’A ’ ) rev(i:i)=’T ’ 



















INTEGER i ,size 
CHARACTER array*(size)
do 10 i=l,size
if ( array(i:i).ne.’ ’ .AND. array(i:i).ne.’C ’ .AND. & 
array(i:i).ne.’G ’ .AND. array(i:i).ne.’T ’ .AND. & 
array(i:i).ne.’A ’ ) then 










d o  1 0  i = l , s i z e  
if ( array(i:i).eq.’c ’) array(i:i)=’C ’ 
if ( array(i:i).eq.’g ’) array(i:i)=’G ’
if ( array(i:i).eq.’t ’) array(i:i)=’T ’
if ( array(i:i).eq.’a ’) array(i:i)=’A ’



















if ( array(i:i).ne.’ ’) first=.true.
if ( array(i:i).eq.’ ’ .AND. array(i+1:i+1).eq.’ ’) last=.true. 
if ( .NOT. last .AND. first) then 
if ( array(i:i).eq.’C ’) size=size+l 
if ( array(i:i).eq.’G ’) size=size+l
if ( array(i:i).eq.’T ’) size=size+l
if ( array(i:i).eq.’A ’) size=size+l
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